adhd uk essay

• Open Access
• Published: 22 April 2022

University students with attention deficit hyperactivity disorder (ADHD): a consensus statement from the UK Adult ADHD Network (UKAAN)

• Jane A. Sedgwick-Müller 1 ,
• Ulrich Müller-Sedgwick 2 ,
• Marios Adamou 3 ,
• Marco Catani 4 ,
• Rebecca Champ 3 ,
• Gísli Gudjónsson 5 ,
• Dietmar Hank 6 ,
• Mark Pitts 7 ,
• Susan Young 8 &
• Philip Asherson 9  

BMC Psychiatry volume  22 , Article number:  292 ( 2022 ) Cite this article

32k Accesses

5 Citations

65 Altmetric

Metrics details

Attention deficit hyperactivity disorder (ADHD) is associated with poor educational outcomes that can have long-term negative effects on the mental health, wellbeing, and socio-economic outcomes of university students. Mental health provision for university students with ADHD is often inadequate due to long waiting times for access to diagnosis and treatment in specialist National Health Service (NHS) clinics. ADHD is a hidden and marginalised disability, and within higher education in the UK, the categorisation of ADHD as a specific learning difference (or difficulty) may be contributing to this.

This consensus aims to provide an informed understanding of the impact of ADHD on the educational (or academic) outcomes of university students and highlight an urgent need for timely access to treatment and management.

The UK Adult ADHD Network (UKAAN) convened a meeting of practitioners and experts from England, Wales, and Scotland, to discuss issues that university students with ADHD can experience or present with during their programme of studies and how best to address them. A report on the collective analysis, evaluation, and opinions of the expert panel and published literature about the impact of ADHD on the educational outcomes of university students is presented.

A consensus was reached that offers expert advice, practical guidance, and recommendations to support the medical, education, and disability practitioners working with university students with ADHD.

Conclusions

Practical advice, guidance, and recommendations based on expert consensus can inform the identification of ADHD in university students, personalised interventions, and educational support, as well as contribute to existing research in this topic area. There is a need to move away from prevailing notions within higher education about ADHD being a specific learning difference (or difficulty) and attend to the urgent need for university students with ADHD to have timely access to treatment and support. A multimodal approach can be adapted to support university students with ADHD. This approach would view timely access to treatment, including reasonable adjustments and educational support, as having a positive impact on the academic performance and achievement of university students with ADHD.

Peer Review reports

Going to university can be an exciting experience, but it is also a daunting and stressful experience for new and returning students. The pressure to do well academically and cope with an array of lifestyle changes, can impact on the mental health and wellbeing of university students, especially students with ADHD who are transitioning from adolescence into adulthood [ 1 ]. This transitional phase defines a critical developmental stage in life termed “emerging adulthood” [ 2 ]. Institutions of higher education (HEIs or universities) are arguably designed for the kind of identity exploration that defines emerging adulthood. This includes leaving home to go to university, and perhaps for the first time, being independent and responsible for managing one’s own finances and dietary needs, whilst at the same time being exposed to a multitude of different worldviews and new opportunities for friendships, romances, partying and work [ 3 ]. Emerging adulthood is also recognised as a peak period for experimentation with substance use or high-risk sexual and other behaviours, and for the onset or exacerbation of mental health problems including self-harm and suicide [ 4 ]. The mental health and wellbeing of university students is a cause for concern [ 1 , 5 ], and the experience of the expert group is that emerging adults with ADHD may be particularly vulnerable during and after transitioning to university.

ADHD is a neurodevelopmental disorder that begins in childhood and frequently persists into adulthood. ADHD is clinically defined by persisting symptoms of inattention, hyperactivity and impulsivity that can cause functional impairments in multiple domains of daily life. In the Diagnostic and Statistical Manual version 5 (DSM-5) [ 6 ], and the International Classification of Diseases version 11 (ICD-11) [ 7 ], diagnostic requirements for ADHD are broadly similar. For this reason, and since the ICD-11 officially comes into effect in January 2022, in this report, reference is made to DSM-5 diagnostic requirements for ADHD in adults. Table 1 lists some typical characteristics and behaviours seen in adults with ADHD, including university students. It is also not uncommon for university students with ADHD to present with co-occurring specific learning differences (or difficulties) (SpLDs), developmental co-ordination disorder (DCD) or dyspraxia as the former term, autism spectrum disorder (ASD), anxiety, depression, personality, eating, and substance use disorders [ 8 , 9 , 10 , 11 , 12 , 13 , 14 ]. A significant majority of university students with ADHD will experience academic difficulties to varying degrees of severity [ 15 , 16 ]. Previous studies refer to “educational or academic outcomes” in terms of academic achievement ( attainment of information and skills learnt, grades obtained on continuous assessments such as standardised examinations or coursework ) and academic performance ( completed years of schooling, enrolment into university, final grades awarded, retention, and progression ) [ 17 ]. Evidence suggests ADHD will impact on these different academic domains in a negative way [ 18 ].

Historical context

The historical context matters a lot for understanding the ways in which ADHD exists in society, including how it is perceived, experienced, and managed. Within UK HEIs, ADHD is perceived and/or conceptualised as a SpLD [ 22 ]. In the special educational needs and disability (SEND) code of practice (0 to 25 years), ADHD is conceptualised as a social, emotional, and mental health difficulty [ 23 ], and in the DSM-5 and ICD-11, ADHD is defined as “ the most common mental health disorder in childhood that often persists in adulthood ” [ 6 , 7 ]. These conceptual differences reflect how the nomenclature, understanding of functional impairments, and clinical characteristics of ADHD within different professional contexts have evolved over time. However for some authors, it was the inception of compulsory education in the late nineteenth century, rather than advances in the medical sciences, that transformed ADHD into a salient societal concern [ 24 ]. In the UK, when compulsory education was first instituted, government funding to schools including salaries for teachers, was based on the numbers of students that attended school for at least 100 days per academic year and passed standardised examinations in the 3Rs (reading, writing, arithmetic) [ 25 ]. This system, known at the time as “payment by results” [ 26 ], is said to have also motivated teachers to raise concerns about students who struggled to pass the 3Rs examinations, and eventually these students were deemed uneducable in mainstream schools [ 27 , 28 ]. Some of these students were described as “… hyperactive, distractible, unruly and unmanageable in school … frequently disturbing the whole class … quarrelsome and impulsive … often leaving the school building during class time without permission ” [ 29 ], p.15).

The Egerton Royal Commission [ 30 ], was first to examine the problem of uneducable students in mainstream schools. In its final report the umbrella term “feeble-minded”, although pejorative today, was introduced to categorise students assessed and certified as needing special education. Arguably, feeble-mindedness is the antecedent for a variety of social, emotional, mental and physical health difficulties that can cause learning problems for a sub-set of students. The early use of the term in education also marked the medicalisation of poor scholastic performance and failure [ 31 ]. Although Still’s observation of a “ moral defect without intellectual impairment ” in school children [ 32 ], was heralded as an early descriptor of the contemporary medical concept of ADHD [ 33 ], the term feeble-minded categorised all “ children who could not be properly taught in ordinary elementary schools by ordinary methods, ” and this included the children who Still had described [ 34 ]. In the early twentieth century, new research on the heritability of intelligence roused a relentless eugenic enterprise to eradicate feeble-mindedness by preventing its procreation [ 35 ]. These events coincided with the development of psychometric tests of intelligence [ 36 , 37 , 38 ], and their use within education became the means by which students were differentiated as either feeble-minded or “simply dull/backward”. The former group of students were sent to newly established residential colonies for care and management under the Mental Deficiency Act 1913, whilst the dull/backward students continued to be educated within mainstream schools [ 39 ].

In 1913, Cyril Burt (1883–1971), the father of educational psychology in the UK, was the first psychologist to be appointed by the London County Council (LCC) to assess students referred under the Mental Deficiency Act. Burt administered psychometric tests with these students, conducted extensive ground-breaking research into educational backwardness, developed standardised tests for use in schools and provided teachers with psychological advice on how best to manage emotional and behavioural disorders in students [ 40 ]. Through his work, Burt argued that intellectual ability was on a continuum, intelligence between boys and girls was the same, academic performance and achievement was variable, and that learning differences (or difficulties) observed in students considered dull, backward, feeble-minded or maladjusted, constituted a single problem [ 41 , 42 , 43 , 44 ]. Burt’s seminal work on educational backwardness was insightful, in the sense that it not only associated causes of backwardness in students with low scores on a psychometric test or other environmental factors, but also with disorders of temperament and conduct. One category within these disorders was the “excitable and unrepressed child” [ 44 ], and descriptors of this disorder are clearly akin to the characteristics of ADHD known today. Interestingly, Burt published his work on the “backward child” in 1937, the same year that Charles Bradley in the USA reported on the positive effects of psychostimulant medication in students who exhibited various behaviour disorders [ 45 ].

The influence of Burt’s work on educational policy and provisions for students with special educational needs was profound [ 46 ]. It was reflected in the landmark Warnock Report on special education [ 47 ]. The recommendations of Warnock Report compelled legislators to enshrine the policy of inclusion within the Education Act 1981, and to introduce the broad concept of “special educational needs” (SEN) to categorise students with a range of learning difficulties and/or disabilities. Descriptors of SEN have since transformed into those listed in the current SEND code of practice (0 to 25 years) [ 23 ]. But despite all this early work, ADHD has continued to be a contentious and controversial medical diagnosis in UK, with one study reporting that only “ 73 hyperactive children were seen at the Maudsley and Bethlem Royal Hospital in London between 1968 and 1980 ” [ 48 ], p.16–17). Following the publication of a protocol for the treatment of ADHD based on DSM-IV criteria [ 49 ], diagnostic rates of ADHD increased in the UK and continued to do so with subsequent publications of clinical guidance for the diagnosis and management of ADHD in children, young people, and adults [ 50 ]. There are still many challenges with regards to timely access to diagnosis and treatment for university students with ADHD, and support for practitioners and educators who have reported ADHD as one of the most challenging disorders to deal with in university students [ 51 ]. These views echoed in the Institute for Employment Studies (IES) report on support for disabled students in higher education in England for the Office for Students (OfS) [ 52 ]. This IES report noted that “… providers [university disability services] were facing a number of, often shared, challenges ...” (p.132), which included dealing with a rising numbers of university students with ADHD and complex mental health needs. One provider quoted by the IES said that:

“… the support provisions for disabled students is understandably being affected by external factors. How to manage that impact is a focus for the disability and dyslexia team… this includes… the number of students with ADHD which has grown dramatically in recent years. This group of students are very challenging to support for both the service and for academic staff. The disability and dyslexia service need training and development to enable them to both support these students and the academic staff working with them ... ” [ 52 ] p.134).

Effects of ADHD within higher education

In the UK, across Europe and worldwide, there is a paucity of research about university students with ADHD. Previous studies mostly seem to originate from North America, where research activity in this topic area has been ongoing since the 1990s, and the impact of ADHD on the educational outcomes of college (or university) students is more widely understood. A comprehensive review of these studies was conducted by Sedgwick [ 21 ], and a summary of the main findings are presented in Table 2 .

ADHD and intellectual giftedness

The relevance of intellectual giftedness to university students with ADHD was considered by the expert group. Intellectual giftedness is another contested concept variously defined as exceptional intellectual ability, academic talent, or high-potential learners, with concurrent traits of creativity, curiosity, effort, and self-motivation [ 53 , 54 , 55 , 56 ]. Intellectual giftedness is referenced in the Canadian ADHD Practice Guidelines [ 57 ], but not in the DSM-5 or ICD-11 [ 6 , 7 ], or other clinical guidelines [ 50 ]. Research suggests that intellectual giftedness can either over-shadow or compensate for attention difficulties, or the behaviours associated with ADHD can over-shadow traits of intellectual giftedness, and that students with both ADHD and intellectual giftedness can be difficult to identify or assess using standardised measures and observational checklists [ 58 , 59 , 60 , 61 , 62 ]. The co-existence of ADHD in intellectually gifted individuals, including university students, is controversial. The theories of positive disintegration [ 63 ], and asynchronous development [ 64 ], have both been used to understand various aspects of intellectual giftedness in students with ADHD. Important areas of current research include the potential misdiagnosis of intellectual giftedness as ADHD, and the occurrence of ADHD and intellectual giftedness as a dual diagnosis [ 65 ].

Intellectual giftedness in students with ADHD is thought to be under-identified by parents, educators, psychologists, and physicians. Brown et al., for instance, reported that “ adults with IQ scores in and above superior range have often sought evaluation and treatment for chronic difficulties with organizing their work, excessive procrastination, inconsistent effort, excessive forgetfulness, and lack of adequate focus for school and/or employment. They question whether they might have an attention deficit disorder, but often they have been told by educators and clinicians that their superior intelligence precludes having ADHD ” [ 66 ], p.161).

Intellectual giftedness does not preclude having ADHD, and in some university students with ADHD it could mitigate some deficits in executive function and allow them to flourish academically or to go on and have successful careers [ 67 , 68 , 69 ]. Some authors proposed that a degree of autism (or savantism) could foster a special talent in gifted individuals [ 70 ], including individuals with ADHD [ 71 , 72 ]. Other authors warn that intellectual giftedness may only be a protective factor for students with ADHD during their pre-18 school years [ 59 , 73 ]. This may change when they transition into higher education where self-directed learning becomes an essential academic skill and when challenges such as living away from a structured home environment, or needing to be more organised, can precipitate a worsening of ADHD symptoms and significant levels of impairment start to emerge [ 74 , 75 ]. These issues may become more apparent in post-graduate students, who are selected based on their undergraduate academic achievements [ 56 , 76 , 77 ]. Empirical studies between 2000 and 2014 about the identification, misdiagnosis and dual diagnosis of intellectual giftedness and ADHD were reviewed by Mullet and Rinn, [ 65 ]. From this review, traits of intellectual giftedness versus ADHD have been compiled for the purposes of clarity. These are listed in Table 3 below.

In sum, this report presents a selective review of previously published literature on ADHD in university students and consensus based on expert opinions. It aims to critically examine and discuss the impact of ADHD on educational outcomes of university students and provide evidence-based, practical advice and guidance on how best to support these students during their programme of studies. Expert consensual advice and guidance in relation to screening and diagnostic assessments for ADHD in adults, specific interventions for university students with ADHD, a potential model for service provision, staff training and development, will contribute to existing research in this topic area.

The purpose of the expert consensus meeting was to formulate practical advice, guidance, and recommendations for supporting medical, mental health, educational and disability practitioners who work with university students with ADHD. This report is based on previously published literature that was identified, selected, collated, and critically reviewed using a framework for scoping studies [ 78 ], as well as the professional experience of the expert group. The consensus meeting was convened by the UK Adult ADHD Network ( www.UKAAN.org ) in July 2017. UKAAN is an organisation founded in 2009 by a group of mental health specialists, responding to NICE guidelines [ 50 ], and recommendations from the British Association for Psychopharmacology (BAP) [ 79 , 80 ], for the purpose of providing support, research, education, and training to professionals working with adults with ADHD. The aims of the consensus meeting were to address the following questions:

Is ADHD a hidden disability within higher education institutions (HEIs)?

Is ADHD a specific learning (difficulty) or difference?

What are the similarities and differences between ADHD, specific learning (difficulties) or differences & other mental health conditions?

What is the impact of stigma?

What constitutes best practice for supporting university students with ADHD?

Service provision

Screening & diagnostic testing

Pharmacological & non-pharmacological interventions

Staff training and development

Meeting attendees included the authors and 48 other mental health, neurodiversity, and disability practitioners, learning assessors and 2 university students with ADHD from England, Wales, and Scotland. The authors who attended the meeting represented a multidisciplinary group of prescribing and non-prescribing clinicians, practitioners, and academics, with extensive experience and expertise in working with adults with ADHD, including university students. Attendees engaged in conversations throughout the day with the aim of achieving consensus. The meeting was structured around presentations on relevant topics that are listed below, and the personal accounts from the 2 university students with ADHD, followed by questions, and answers (Q&As).

The first author facilitated discussions among the attendees to elicit verbal accounts of experience and to reach a consensus position on the topic being discussed. At the end of the meeting, the first author presented a summary of the main points previously agreed (which are listed in Table 4 ), and then asked the attendees to raise a hand to indicate whether they agreed with each point being raised. This is line with the phenomenological methodological framework that was used to gain an emic or “insiders” perspective of the attendee’s experiences, knowledge, and expertise of working with university students with ADHD [ 81 , 82 ]. The consensus meeting started with an overview of the neurobiology of ADHD to set the scene, then invited speakers presented on the following topics:

The effectiveness of stimulant medication in treating ADHD.

Academic coaching for university students with ADHD.

The SpLD Assessment Standards Committee (SASC) guidelines for the assessment of ADHD in university students.

Tele-psychiatry: Internet based treatment services for university student with ADHD.

The student experience: What is it like to be a university student with ADHD?

The attendees and speakers consented to the presentations and discussions being audio recorded. After the meeting, the recording was transcribed verbatim with care taken to remove all identifiable information. Authorship of the manuscript was based on involvement during the meeting, a willingness to work on the manuscript after the meeting, clinical and professional expertise in the assessment and treatment of ADHD in university students. The first author (JSM) consolidated the presentations, data from the transcripts and notes relevant to the main points agreed in the meeting, into a manuscript that was circulated amongst the authors for review, revision, final agreement, and approval. This manuscript reflects the clinical experience and expertise of the authors and is supported by published literature.

Results and consensus outcome

The series of questions and summary of main points addressed during the meeting were collated and are discussed below. A summary of the main recommendations is listed in Table 10 .

Only one study was found that reported on the prevalence of ADHD in UK university students. In this study Pope et al. [ 83 ] used the Conners’ Adult ADHD Self-Rating Scale to assess for symptoms of ADHD in 1185 undergraduate psychology students from four UK universities. The findings revealed that about 7% of these students self-reported above-threshold symptoms of ADHD. In a study from the USA, DuPaul et al. [ 84 ] reported that at least 25% of college students with disabilities were diagnosed with ADHD. Among university students in China ( n  = 343), and in the USA ( n  = 283), ADHD was reported to be around 5% in the USA cohort and 8% in the Chinese cohort [ 85 ]. These data clearly depict variability, with some reported rates suggesting a higher prevalence of ADHD among university students, when compared to the reported worldwide prevalence estimate of 2–3% for ADHD in adults [ 10 ]. However the studies that reported higher prevalence estimates (e.g., Norvilitis et al. [ 85 ] did seem to have determined the presence of ADHD based on a count of symptoms alone, and did not assess functional impairments to meet full diagnostic requirements for ADHD. Perhaps if functional impairments had also been considered, prevalence rates of ADHD in university students may have been similar to the prevalence rates reported for adults [ 86 ].

University students with ADHD are part of a much bigger group of disabled students that are represented within the widening participation (WP) strategy that forms a major component of higher education policy in the UK [ 87 ]. The WP strategy requires HEIs in the UK to collect, analyse, and respond to data on disabled students. To do so, HEIs utilise UCAS (Universities and Colleges Admissions Service), codes and categories of disability listed in Table 5 . As shown, ADHD is listed “ G – Specific Learning Difference e.g., dyslexia, dyspraxia, or ADHD .” The Higher Education Statistical Agency (HESA, https://www.hesa.ac.uk ) also collect, process, and publish data about disabled students within higher education in the UK. Figure 1 depicts percentages of the HESA Data for “ UK domiciled students’ enrolments by disability and sex” based on a total number of 307,975 for the academic years 2014/15–2018/19 [ 22 ]. From this data it is also not possible to ascertain a prevalence estimate for ADHD among university students or even to identify if ADHD exists within higher education.

Disabled university students in the UK. Source: Table 15: UK-domiciled student enrolments by disability and sex , for the academic year 2018-19, (total number of disabled students 316,380) [ 22 ]. NB: There are high rates of overlap between ADHD and both SpLDs and mental health conditions, but the prevalence of ADHD is unknown, because there is no separate category for it

Figure 2 depicts in percentages published data from 25 HEIs in Ireland, based on a total number of 12,630 university students who declared a disability for the academic year 2016/17 [ 88 ]. There are clear similarities between this data and the HESA data depicted in Fig. 1 . But there are also differences in the numbers of university students who declared a mental health condition (27% in the UK vs. 13.9% in Ireland), a specific learning difference (UK 36% vs. Ireland 41.4%) and autism spectrum disorder/ASD (UK 4% vs. Ireland 5.4%). In Ireland, data is also collected on university students who declare a developmental co-ordination disorder (DCD, or dyspraxia, 6.1%) and ADHD (5.2%), but similar data is not collected in the UK. During the consensus meeting there was unanimous agreement that ADHD should no longer be subsumed under the category of a SpLD. The obvious consequence of continuing to do so is that a prevalence estimate for ADHD in UK university students will always be hard to ascertain.

Disabled university students in Ireland. Source: Fig. 3 Breakdown of students by Category of Disability 2016/17 (total number of disabled students 12,630) [ 88 ]

Recommendation 1. The categorisation of ADHD

The expert group recommends that ADHD should no longer be subsumed under the category of a SpLD in HESA data return categories or by university services and should be coded or categorised separately. If ADHD continues to be coded or categorised as an SpLD then no specific data about the numbers of university students who declare ADHD as a disability within UK HEIs will be collected. ADHD is a mental health condition and not a SpLD. ADHD has specific diagnostic criteria within the DSM-5 [ 6 ], and ICD-11 [ 7 ], as well as efficacious treatments (medication and psychosocial interventions) [ 89 , 90 ]. A separate code to categorise ADHD within UK HEIs could result in greater recognition of the disorder and increase understanding about how it impacts on academic performance and achievement.

What are the differences between ADHD and SpLDs?

Dyslexia, dyscalculia, dysgraphia, and dyspraxia (or DCD) and ADHD are all categorised as SpLDs within UK HEIs. However, in the DSM-5, dyslexia, dyscalculia, and dysgraphia are grouped together under a single diagnostic category of “specific learning disorder” (SLD, or learning disorder), whilst DCD is classified separately as a motor disorder and ADHD as a neurodevelopmental disorder [ 6 ]. SpLDs are not synonymous with SLD, but a university student who has been diagnosed with a SLD can also expect to meet criteria for a SpLD, be registered as disabled and qualify for reasonable adjustments under the Equality Act 2010. Specifiers and characteristics of SLD and typical SpLD terms used in higher education are listed in Table 6 . Unlike ADHD, there are no known medical treatments for SLD (or SpLDs), therefore reasonable adjustments (or accommodations) are required to limit their impact within educational settings. Reading disorder (RD, e.g., dyslexia) is the most prevalent SpLD reported to account for up to 80% of all SpLDs [ 91 ]. Bidirectional comorbidity between RD and ADHD which is estimated at 25–40%, is likely due to shared genetic risk factors [ 92 ]. This may also explain why deficits in executive function are seen in both ADHD and RD [ 93 , 94 ]. Executive functions (EF) are described as a set of top-down mental skills essential for academic performance. In Table 7 , EFs are conceptualised in terms of their organisational and regulatory functions. The three commonly described EFs are inhibitory control, working memory and cognitive flexibility [ 95 , 96 ]. Although research suggests that deficits in EF can adversely impact academic functioning due to the problems they can cause with sustaining attention, forgetfulness, procrastination, organisation skills, prioritising, regulating alertness, emotional and behavioural self-control, psychometric tests of EF are still not sensitive enough to assess for the core deficits of ADHD [ 97 , 98 , 99 , 100 , 101 , 102 , 103 ].

The Baddeley and Hitch [ 107 ] conceptual model of working memory (WM) in Fig. 3 , proposes that WM is a core EF for storing and manipulating information, and with a central role in attention, allocating data to its slave systems (phonological loop and visuo-spatial sketchpad), performing task switching, mental arithmetic, problem solving and interfacing with long-term memory through the episodic buffer. The episodic buffer acts as a temporary store for the phonological loop, which processes spoken and written information, whilst the visuo-spatial sketchpad processes visual imagery. Although this model can be used to understand the importance of WM in academic tasks such as reading, comprehension, verbal reasoning (phonological loop), navigation (visuo-spatial processing) and problem-solving (central executive) [ 107 , 108 , 109 , 110 , 111 ], the model can also be used to understand how deficits in WM might occur in both ADHD and reading disorder [ 93 ]. Reading disorder (e.g., dyslexia) is defined by deficits in decoding the speech sounds of words and structure of language (phonological weakness), fluency (an inability to ready quickly with appropriate expression) and processing speed [ 11 , 91 , 93 , 102 ].

Model of Working Memory (Adapted from Baddeley [ 111 ]

Processing speed (PS) is not an EF per se, rather it is said to be a cognitive ability that describes the amount of time it takes to identify, understand, react, or respond to information received, whether it be visual (letters and numbers), auditory (language) or movement [ 112 ]. Since PS is surmised to impact on WM, phonological loop and visuo-spatial sketchpad processes, and the fine motor co-ordination associated with DCD, it’s impact on academic performance is also said to be direct [ 113 ]. PS is an index score on the WAIS (Wechsler Adult Intelligence Scale), measured by rapid automatized naming of pictured objects, letters, numbers, and colours [ 112 ]. Slow PS or PS deficits, often identified by a low PS score on the WAIS, has been associated with reading disorder [ 102 ], ASD and ADHD [ 114 ]. This also means when a student is identified with PS deficits on the WAIS for instance, certain academic tasks, such as an examination which requires “ an ability to quickly come up with an answer and retrieve information from memory ”, may take longer to complete, hence these students tend to be awarded extra writing time for examinations as a reasonable adjustment [ 115 ], p4). PS deficits are also implicated in the comorbidity between ADHD and reading disorder [ 116 ], the combined effect of which may produce more severe learning problems than when each of these disorders occurs on its own [ 11 , 117 , 118 ]. High rates of comorbidity are also reported between ADHD and other SpLDs (e.g., dyscalculia and dysgraphia), and other disorders such as DCD and ASD, with similar combined effects as those surmised between ADHD and RD, but a paucity of research limits understanding of the severity of cognitive deficits in these comorbidities and their impact on academic functioning [ 8 , 14 , 70 , 119 , 120 , 121 ].

Recommendation 2. ADHD and SpLDs

Comorbidity between ADHD and other neurodevelopment disorders, which include SpLDs, adversely impacts on academic functioning. The expert group therefore recommends screening for ADHD as part of routine practice for university students who report learning difficulties that seem to be associated with dyslexia, dyscalculia, dysgraphia, dyspraxia and/or ASD, not only because these conditions are highly likely to co-occur [ 8 , 11 , 14 ], but ADHD can be missed if a student is only screened for SpLDs and/or ASD. For students that screen positive for ADHD, a referral for treatment and management by a suitably qualified mental health professional (e.g., student health GP, psychiatrist, or mental health nurse/practitioner) is important. Although ADHD on its own can provide an explanation for learning problems within higher education, it can also add complexity to the learning problems associated with SpLDs, DCD or ASD. These complexities need to be considered when assessing for, and/or awarding reasonable adjustments. Screening tools that are used in routine practice are listed in Table 8 .

What are the differences between ADHD and other mental health conditions?

It is equally important to differentiate ADHD from other mental health conditions and to consider the impact of these conditions on university students with ADHD when they do co-occur. Year-on-year increases in the number of students declaring a mental health condition at university have been observed, with current prevalence estimates of 27% amongst university students who declare a mental health disability before or during their programme of studies (see Fig. 1 ). A study by Anastopoulos et al. [ 16 ] examined rates and patterns of co-occurring disorders in 443 university students with ADHD. The findings of this study revealed that 55% of these students had at least one comorbidity whilst 32% had two or more, and that commonly reported comorbidities with ADHD were depressive and anxiety disorders. These elevated rates differ from rates reported in an epidemiological study conducted in 20 high, medium, and low-income countries involving 26,774 adults with ADHD. This study found that 23% of these adults with ADHD had at least one mental health comorbidity, while 14% had two or three comorbidities, and that commonly reported comorbidities with ADHD were also anxiety disorders (34%), mood disorders (22%), as well as behavioural disorders (15%) and substance use disorders (11%) [ 10 ]. Similar findings were reported in qualitative studies, although the participants in these studies, also reported positive aspects of ADHD such as high levels of energy and drive, creativity, hyper-focus, agreeableness, empathy, self-acceptance, and a willingness to assist others [ 132 , 133 ].

During the consensus meeting the discussion mostly focused on university students who frequently reported anxiety and depression. Different types of anxiety (e.g., generalised anxiety disorder, social anxiety, specific phobias, agoraphobia, panic disorder, substance/medication induced anxiety ), or depressive disorders (e.g., mood dysregulation disorder, major depressive disorder, dysthymia, premenstrual dysphoria, substance/medication induced depression ), were discussed in relation to ADHD. Major depressive disorder (MDD) does show some overlap with ADHD symptoms such as poor concentration and working memory performance, but in MDD these characteristics are episodic and only arise during periods of low mood, anhedonia (loss of interest/enjoyment in ordinary experiences), or when there are ruminations dominated by negative content, and appetite disturbances, which are not characteristic of ADHD [ 134 ]. In contrast, people with ADHD usually present with attention regulation problems. This means they may be able to focus during highly stimulating or interesting tasks and activities, but problems with concentration will remain regardless of mood state [ 19 ]. Poor concentration and restlessness are also symptoms that are shared between anxiety disorders and ADHD. Anxiety disorders are characterised by fluctuations in pathologic worry, fear, and somatic symptoms, which drive concentration problems, whereas in ADHD, problems with attention and restlessness, drive concentration problems and reflect persistent traits that are independent of anxiety [ 134 ].

University students with ADHD can present to medical, counselling, and disability services with problems related to anxiety and/or depression, because challenges of university life can also play an important role in affected mental health. Both anxiety and depression are frequently co-occurring conditions in adults with ADHD [ 10 ], as well as in university students with ADHD [ 16 ]. However, it is still important to be aware that symptoms of ADHD can mimic both anxiety and depression [ 19 ], and that anxiety and depression can in turn affect attention, concentration, processing speed, and motivation, giving rise to poor performance on reading, writing, attending classes and group work [ 135 ]. University students with ADHD can also be prone to “test anxiety” and experience disabling levels of worry, emotional and somatic symptoms, that exacerbates their ability to focus and perform during evaluative assessments such as examinations. This may further increase the risk that they achieve poor grades, or delay completing their programme of studies [ 136 , 137 ]. More generally, symptoms of ADHD can be misdiagnosed for anxiety, mood, or personality disorders. This may be an issue for females with ADHD whose symptoms are more likely to reflect internalising symptoms and emotional dysregulation [ 138 ].

Emotional dysregulation is a prominent feature in ADHD and is listed in the DSM-5 as a characteristic that supports the diagnosis of ADHD [ 6 ]. Research suggests that up to 80% or more adults with ADHD report significant levels of emotional dysregulation/lability marked by irritability, volatility, a hot temper, low frustration tolerance and sensitivity to criticism [ 139 , 140 , 141 ]. These attributes do reflect a part of the normal range of mood symptoms for people with ADHD, but if severe, then they can also be misconstrued for MDD, bipolar disorder or a personality disorder. Emotional lability (EL) in adults with ADHD tends to manifest as short-lived emotional outbursts, or feelings of irritability, frustration, or anger that is often (but not always) in response to daily events [ 140 ]. Studies on EL in adults with ADHD also suggest that it is more closely linked to the development of low self-esteem and poor self-concept, when compared to the other core features of ADHD [ 140 , 142 ]. University students with ADHD who have problems with EL are more likely to encounter additional challenges with making and maintaining academic and social relationships [ 143 ], or with participating in group work, team sports, societies, or other activities at university, especially if they frequently express anger, sadness, or anxiety when with others [ 144 ].

University students with ADHD who do not cope well with anger or sadness may also use tobacco, alcohol, cannabis, or other drugs; sex, gambling, or gaming as coping strategies [ 145 , 146 , 147 ]. Some students with ADHD may not be able to control their alcohol intake for instance, and binge drink often or report more drinking-induced blackouts, loss of friends or romantic partners as a result of their drinking habits [ 147 ]. In the study by Rooney et al., [ 148 ], although students with ADHD did not report higher levels of alcohol use, they did report more dangerous/hazardous use. In another study when university students with ADHD escalated their substance use, they increasingly skipped classes and reductions in their academic grades were observed [ 149 ]. Although similar problems are seen in clinical practice with other drugs of abuse such as cocaine [ 150 ], some drugs are used to control symptoms of ADHD. For example, cannabis may help reduce some ADHD related problems such as restlessness, EL and problems getting to sleep [ 151 ]. In contrast to poor mental health, emotional wellbeing is increasingly being viewed as important for enhancing a student’s motivation to learn, academic performance and interpersonal skills. Studies have shown that reducing stress, and increasing enthusiasm, contentment, joy, hope, pride, exuberance, and elatedness are linked to improvements in academic self-efficacy, interest, effort, engagement, performance, and achievement [ 152 , 153 , 154 , 155 , 156 ]. There are also positive aspects of ADHD that can be useful at university [ 133 ].

Recommendation 3. ADHD and mental health conditions

The expert group recommends that university students who present with enduring anxiety and depression, and report persistent problems with learning or studying, should be screened for ADHD. ADHD can mimic these conditions, and likewise, anxiety and depression can mimic ADHD. Anxiety and depression may also reflect a normal stress response to the educational and psychosocial impairments of ADHD. Screening for ADHD should therefore be conducted in all students diagnosed with, or frequently complaining about, anxiety or depression (or other chronic mental health problems), particularly when they are taking medication and there is no or only limited improvements in their mental state. For students that screen positive for ADHD, a referral for treatment and management by a suitably qualified mental health professional (e.g., student health GP, psychiatrist, or mental health nurse/practitioner), is important.

What is the impact of stigma on university students with ADHD?

Stigmata are the beliefs, attitudes and structures that interact at an individual, group, or institutional level, to discriminate against a person based on a perceivable social characteristic that sets them aside from others [ 157 ]. ADHD, a diagnostic label, is a perceivable social characteristic that can be stigmatised as laziness, bad behaviour, or as having “special needs” [ 158 , 159 ]. There are lingering myths, misconceptions, negative stereotypes, and labels associated with ADHD [ 160 ]. Some medical professionals in the UK, Europe, and Australia, have expressed doubts about whether ADHD is real, over-emphasising the aetiological role of parenting, or questioning the role of stimulant medication in its treatment [ 161 ]. In one study a group of university students were asked to rate the likelihood of interacting with, collaborating on a group project with, getting to know, becoming friends with, living with, working with, or dating a peer with either ADHD, a general medical condition, or an ambiguous flaw such as perfectionism. Peers with ADHD were rated as less socially desirable than peers in the other two groups [ 162 ]. In young people with ADHD, although self-stigma can present as a sense of feeling different from same age peers or by negative self-evaluations, some young people have also challenged ADHD related stigma by openly disclosing and talking about their diagnosis [ 163 ].

Some professionals may fear treating a “fake disease” or causing a drug dependency by prescribing stimulant medication, even though there is no empirical evidence to support these views [ 50 , 158 , 164 ]. Missing or failing to identify ADHD is more likely to happen in university students who are intellectually gifted, getting good grades, or in those, particularly females, who may be misdiagnosed with anxiety, depression, eating or personality disorders [ 50 , 138 , 158 ]. Some studies from the USA suggest that university students without ADHD can malinger for the purposes of obtaining a prescription for stimulant medication for use as “study drugs” [ 165 , 166 ]. Malingering with ADHD for this purpose may be a phenomenon more often observed in the USA, where ADHD is more commonly diagnosed and treated in primary care. This is not the same as in the UK and Europe more generally, where ADHD in adults is an under-diagnosed and under-treated condition and suitably qualified and trained medical or non-medical prescribers (e.g. mental health nurses or pharmacists) treat ADHD [ 19 ]. From the perspective of the expert group, concerns about malingering can further stigmatise university students with ADHD in the UK, as well as discourage disclosure, bias the way a screening or diagnostic assessment is conducted and result in a failure to recognise a legitimate disorder with an effective treatment. The experience of the expert group is that malingering with ADHD is not common (even unusual) for university students in the UK. Instead, they tend to work exceptionally hard to overcome their deficits associated with ADHD and still experience academic outcomes that fall below that expected from their general intellectual ability. The need to tackle the stigma associated with ADHD was discussed during the consensus meeting, in terms of how it deterred disclosure, seeking a formal diagnosis, taking medication, or seeking additional support. Concerns about disclosing ADHD (or other mental health conditions) were also noted in the Institute for Employment Studies report to the Office for Students [ 52 ].

Recommendation 4. ADHD and stigma

The expert group recommends that targeted programmes of training for university student support staff should include psychoeducation, how to screen for ADHD and use recommended strategies for supporting university students with ADHD. This training can also be used to raise awareness about the potential stigma associated with ADHD, its consequences and potential impact on the screening and diagnostic process, willingness to disclose ADHD at university and accept treatment.

What is best practice for supporting university students with ADHD?

In the UK, clinical guidance recommends that the medical diagnosis of ADHD must be done by a suitably qualified practitioner, and with primary care staff providing support through shared care protocols [ 50 ]. The expert group is aware that at present, waiting times for access to treatment via specialist NHS adult ADHD clinics can be anything of up to two years or longer in some areas of the country. Given the high cost of tuition fees for university and living expenses, plus added pressures to complete a university degree on time, students with ADHD simply cannot afford to wait two or more years to access treatment in specialist NHS services, without risking poor academic performance, failure, drop-out or increased burden of illness. For some of these students the misuse of caffeine products, cannabis, alcohol, or stimulants (licit or illicit) may seem like attractive options for self-medication. Seeking an educational diagnosis of a SpLD, funded through the university disability service, maybe an attractive option that can enable access to educational support. But if the core symptoms of ADHD remain untreated, students with ADHD can continue to experience learning (and possibly other) problems during their time at university.

In one systematic review of 176 studies about the long-term educational outcomes of untreated versus treated ADHD, academic outcomes were found to be worse in students with untreated ADHD when compared to their non-ADHD peers, after controlling for IQ [ 18 ]. Another finding was that academic outcomes improved significantly when multimodal treatment was used, in comparison to when pharmacological or non-pharmacological treatments were used alone [ 18 ]. The provision of rapid access to treatment for university students with ADHD maybe challenging for clinicians working in specialist NHS services. But the expert group has found that some HEIs are using funds from their disability services budget to fund private diagnostic assessments for their students, and are commissioning medical treatment (e.g., bespoke services through the NHS or privately). These HEIs in turn note these initiatives in their “access and participation plans” (APPs) for the OfS, to demonstrate how they are improving equality of opportunity for students with ADHD, who traditionally experience poor educational access, achievement, and attainment [ 21 ].

Recommendation 5. Service provision

The expert group recommends that a rapid access pathway of care for university students with ADHD be developed collaboratively between university central support services, and NHS primary and secondary care, or private providers. University disability services currently fund diagnostic assessments for SpLDs. This budget could also be made available to university students with ADHD to enable them to at least obtain a diagnostic assessment and reasonable adjustments. The expert group provides an example of a potential support pathway for university students with ADHD, which is presented in Fig. 4 .

Potential Support pathway for university students with ADHD

Which screening tools and diagnostic assessments are useful?

Screening tools are used to indicate if symptoms of ADHD and/or any other co-occurring conditions that are likely to complicate the learning problems that university students with ADHD are present or not. Screening for ADHD and other potential comorbidities is done routinely in clinical practice, because it’s important to differentiate the conditions underlying the student’s presenting symptoms and consider whether they may or may not require additional reasonable adjustments or support from other services (e.g., GP, mental health, or counselling). A widely used screening tool for ADHD based on DSM-5 diagnostic criteria, is the World Health Organisation Adult ADHD Self-Report Scale (ASRSv1.1) [ 122 ], now updated to an online DSM-5 version (see Table 8 for further details and weblinks). The 18-item ASRS consists of all the diagnostic symptoms of ADHD and is useful as a screener for gathering information about ADHD symptoms that can be examined more in-depth during a diagnostic assessment. If the ASRS screener is positive for ADHD, and there are indications of sustained difficulties with attention, motor restlessness/overactivity or impulsive behaviour, then it must trigger a full diagnostic assessment by a suitably qualified practitioner.

The SpLD Assessment and Standards Committee (SASC) guidance for the assessment of ADHD, also states that “ practitioner psychologists and specialist teacher assessors who have relevant training can identify specific learning difficulties and patterns of behaviour that together would strongly suggest a student has ADHD; and in this situation they can make relevant recommendations for support at Further and or Higher Education institutions. Such diagnostic assessments should be accepted by SFE in support of an application for Disabled Students’ Allowance ” [ 167 ], p.2). This means university students can have indicators of ADHD identified as part of a SpLD diagnostic assessment and then use their diagnostic report to apply for reasonable adjustments and DSA (Disabled Student Allowance). However, even with additional educational support in place (e.g., DSA, reasonable adjustments, or sessions of study skills), ADHD can continue to impair academic functioning if it remains untreated [ 18 ]. In a few cases it can be hard to tell if ADHD with or without co-occurring learning disorders or mental health symptoms, including intellectual giftedness, are different facets of the same condition or reflect separate disorders [ 168 ]. For instance, a student with undiagnosed ADHD who keeps performing badly academically, despite studying extra hard, may start to worry excessively or feel like a failure and then become depressed. This student may seek help because they are feeling anxious or depressed, but in fact the underlying condition is ADHD.

There are effective screening tools for anxiety, depression and substance misuse that can be used with university students with ADHD. The 10-item Kessler Psychological Distress Scale (K10) can be used to screen for anxiety and depression [ 125 ], or the 16-item Penn State Worry Questionnaire (PSWQ) can be used to screen for pathological worry, which is a dominant feature in generalised anxiety disorder [ 126 ]. There are useful screening tools in the appendices of the Improving Access to Psychological Therapies (IAPT) manual, including the Generalised Anxiety Disorder scale (GAD-2, GAD-7), Panic Disorders Severity Scale (PDSS), and the Patient Health Questionnaire (PHQ-9, for depression) [ 128 ]. The Simple Screening Instrument for Substance Abuse (SSI-SA) (Center for Substance Abuse Treatment, 1994) is widely used as a brief screen by practitioners and assessors with little experience of substance misuse [ 127 ]. NICE clinical guidance [CG123] also offers very clear advice and guidance for screening common mental health disorders, and recommends that if a practitioner conducting the screen identifies a possible anxiety disorder or depression, and they are not competent to perform a full mental health assessment, then they must refer the student to an appropriate healthcare professional [ 169 ].

Some students may have additional problems related to a SpLD (e.g., dyslexia) or ASD. Useful screeners for these conditions are the Adult Dyslexia Checklist which is available for free from the British Dyslexia Association website [ 124 ], and the Autism-Spectrum Quotient (AQ-10), is also available for free download [ 123 ]. If a student with ADHD screens positive for a SpLD or ASD, then a shared decision with the student can be made about the usefulness or value of a referral for a diagnostic assessment of these comorbid conditions. It might be for example, that a positive screen of either condition and careful questioning about functional impairments, will be enough to assess their impact on studying and how best to mitigate them with additional support (e.g., counselling, specialist mentoring, academic coaching, extra writing time for examinations). There is also evidence which suggests that once the core symptoms of ADHD are treated, problems related to co-occurring SpLDs, ASD traits, anxiety or depression may in turn improve [ 9 , 158 , 170 ]. During the shared decision-making process, an agreement with the student can be also reached about whether to include results of a positive screen for a SpLD and/or ASD in their diagnostic report, which can include a write-up about the potential complexities these conditions might add to a student’s ability to study effectively. Further details and weblinks for the screening tools are provided in Table 8 .

At present there are no neuroimaging, genetic, neurochemical, or neuropsychological diagnostic tests for ADHD that are sufficiently sensitive or specific. Neuropsychological tests such as Stop Signal Reaction Time, IQ, or various computerised tests of executive functions (e.g., CANTAB) or QB-Test, can however, complement a diagnostic assessment for ADHD and provide additional information about cognitive performance [ 171 ]. Some authors (e.g., Brown [ 98 ], conceptualise ADHD as a disorder of executive function (EF), and many learning problems that university students with ADHD experience may be due to deficits in EF (e.g., poor organisation, planning and time management skills, inattention, or emotional lability) [ 172 ]. Although these EF deficits are not well reflected in cognitive performance tests [ 173 ], an assessment of EF behaviours such as those captured by the BRIEF questionnaire are strongly related to ADHD and associated functional impairments [ 174 ]. The recommendation of the expert group (and all national/international guidelines) is that a diagnostic assessment for adults with ADHD should be based on self-reported symptoms, which are best obtained by using a semi-structured in-depth diagnostic interview. An example of such a tool is the “Diagnostic Interview for Adult ADHD” (DIVA-5), which is based on the symptom and impairment criteria of the DSM-5 [ 129 ]. The ACE+ is another diagnostic tool that can be useful, and it has the option to use either DSM-5 or ICD-11 diagnostic criteria [ 130 ]. The DIVA-5 is available for a one-off fee of 10 Euro whereas the ACE+ is free to download, with digital versions in English and other languages (see Table 8 for further details and weblinks). Collateral information can also be obtained from informants such as close friends or relatives, and school records, especially for the evaluation of age of onset.

ADHD in adults is diagnosed when 5 or more symptoms of inattention and/or hyperactivity-impulsivity are present, and with several of them being present before 12 years old. These core symptoms must have persisted for at least 6 months, and in clinical practice the expectation is of a chronic trait-like course from the age of onset during childhood or early adolescence. The symptoms of ADHD should be to a degree that is inconsistent with the developmental level for that individual and must cause functional impairments in 2 or more settings (e.g., at home, university, work, with friends or relative, or in other activities) [ 6 ]. During the diagnostic process conducting a detailed evaluation of how the student’s presenting symptoms impact on their academic productivity is essential. Potential education-related impairments due to ADHD are listed in Table 9 . Individually assessing and writing about education-related problems in the student’s diagnostic report will help practitioners working in student disability services to devise personalised support, as well as allow for the effectiveness of this support to be evaluated. The Weiss Functional Impairment Rating Scale – Self Report (WFRIS-S), is a useful tool for assessing and monitoring changes in functional impairments associated with ADHD in different domains [ 131 ].

Practitioners and assessors need to be aware that ADHD symptoms and functional impairments present differently in each student and their impact can also change over the course of their programme of studies [ 19 ]. The experience of the expert group is that some students meeting diagnostic criteria for ADHD may not want to take prescribed medication in the first instance. But as their programme of studies progresses this may change, and the student may want and require medication to reduce core symptoms of the disorder. While psychoeducation, and environmental modifications (including reasonable adjustments) can help support university students with ADHD (and may be sufficient in some cases), only medication has been found to reduce core symptoms [ 89 ]. It is the experience of the expert group that university students with ADHD often have well developed compensatory strategies such as being overly organised, almost in an obsessive manner, or studying extra hard for long periods of time to ensure adequate performance. They may also have lost the usual structured support of parents and school when they were younger, so that impairments can increasingly accrue as their course develops. During diagnostic assessments, some students can find it hard to remember what their ADHD symptoms and impairments may have been like during childhood. When this happens, it is best to focus on their presenting symptoms and establish whether at least 5 or more of them are currently present and cause impairment, then track back in time to establish as far as possible an age at which current symptoms started.

In most cases of ADHD an individual is unable to identify a clear age of onset and they have the perception that the symptoms were always present. A typical response is that the symptoms have been present for as long as they can recall. Remembering symptomatic behaviours in childhood is especially hard when the student’s parents or other care givers have given them a lot of support during their academic career, or provided them with structure and routine, or when the student, had predominantly inattentive symptoms in childhood, that were not noticed either by their parents or teachers. This is more likely in females (and some men) with ADHD, who tend to present with predominantly inattentive symptoms and few hyperactive-impulsive symptoms or less disruptive behaviour [ 50 , 138 , 175 ]. The gender bias in ADHD seems to become less skewed in adulthood when women with ADHD may be diagnosed, often for the first time [ 138 ]. Practitioners and assessors conducting a diagnostic assessment need to be aware that female students can present with study related problems due to ADHD for the first time whilst at university. These students may or may not have a previous diagnosis of another mental health condition, which will need to be reviewed if they are diagnosed with ADHD [ 138 ].

During face-to-face diagnostic assessments, compensatory strategies can be minimised. For instance, the student may not recognise that sustaining attention or organisation is problematic for them, when a more objective appraisal suggests that this is a persistence problem. This can occur because symptoms of ADHD reflect lifelong traits, or because the student has well developed compensatory strategies. When this happens, it’s best to assess the degree of effort that the student needs to put into maintaining a compensatory strategy (for example, if the student did not put in extra effort to be organised then what would happen ?). Students with severe ADHD may be easier to screen and diagnostically assess, but if these students have developed good compensatory strategies (as discussed in the section on intellectual giftedness), it can be hard to determine how severe and impairing their ADHD symptoms are in other functional domains (e.g., social relationships). It may also be at a time when compensatory strategies are sufficient to mitigate ADHD related impairments, but this may not always be the case as their programme of studies progresses. Some students may present with “subthreshold symptoms” of ADHD (i.e., symptoms just below the threshold for a diagnosis of ADHD to be made), yet they appear to be significantly impaired by these symptoms and therefore need additional support, and perhaps treatment. The experience of the expert group is that impairments are also informed by co-morbidities and that several sub-threshold comorbidities (particularly of neurodevelopmental disorders) can be more impactful than a single disorder above the diagnostic threshold [ 176 ].

Recommendation 6. Screening tools and diagnostic assessments

The expert group recommends that practitioners and assessors be given training in how to screen for and diagnostically assess ADHD using robust and evidence-based rating scales, screening tools, and standardised clinical interviews. This training should include how to conduct a detailed evaluation of education related functional impairments, write up a diagnostic report with recommendations for reasonable adjustments and make a direct referral for medical treatment if requested, to a suitably qualified practitioner with expertise in the management and treatment of ADHD in adults (e.g., a psychiatrist or mental health nurse/pharmacist non-medical prescriber). A list of standardised screening and diagnostic tools are presented in Table 8 below.

What pharmacological and non-pharmacological interventions are useful?

Following initial psychoeducation about ADHD and its impact, NICE guidance [ 50 ] recommends making “environmental modifications”. In the context of university students with ADHD environmental modifications can take the form of “reasonable adjustments” to programmes of study under the Equality Act 2010. Potential learning problems associated with ADHD and potential reasonable adjustments are listed in Table 9 . Adjustments can also be made to study environments (e.g., making available a quiet study room in the library, recommend taking frequent breaks when studying, breaking down daily targets, using digital diaries and reminders, regular forms of exercise) [ 172 ]. If these adjustments/ modifications have been applied and functional impairments continue in at least one domain (e.g. academic performance, or studying/learning difficulties), then medication should be considered.

NICE guidance [ 50 ] recommends psychostimulant medication (i.e., methylphenidate or lisdexamphetamine) as first-line medical treatment for ADHD in adults. Psychostimulant medications are among the most effective medications in use within adult mental health [ 89 ], and among the most efficacious of all common medical drugs [ 177 ]. Stimulant medications often produce a substantial reduction in ADHD symptoms and associated impairments. However, stimulant medications can also have adverse effects, which in most cases are either dose-related, mild, or transient such as headache, reduced appetite, nausea, palpitations, difficulty falling asleep and dry mouth [ 89 ]. In a few cases, these adverse effects may be undesirable, and an individual may decide to stop using stimulant medication. Stimulant medications can also increase blood pressure and heart rate, therefore people who take these medications are assessed at baseline and monitored during their treatment [ 50 ]. Empirical research about the efficacy of treating university students with ADHD is rare and the extent to which prescribers consider the unique demands of university life when prescribing medication to students is unknown [ 178 ].

The first randomised controlled trial of lisdexamphetamine with a sample of 24 university students diagnosed with ADHD was conducted by DuPaul et al., [ 179 ]. In this study, lisdexamphetamine was administered over a 5-week period and large reductions in the students ADHD symptoms were observed, alongside improvements in their task management, planning, organisation, use of study skills and working memory. Although the short duration of this study precluded an assessment of academic functioning over the long-term, in other studies, university students with ADHD who took medication did report improvements in their note taking, scores on tests, writing output and completion of course work [ 180 ]. In a pharmaco-epidemiological study from Sweden young people with ADHD taking medication were also found to have better scores in standardised university entrance examinations when compared to peers with ADHD not taking medication [ 181 ]. It is noted, however, that a substantial number of university students with ADHD do not take their medication as prescribed [ 182 ]. Some university students with ADHD may use their medication flexibly, with optimum dosing during times of writing assignments or studying for examinations and then no medication on days without academic work, e.g., at weekends or during holidays [ 183 ]. When treating university students with ADHD, prescribing practitioners therefore need to be open to discussing the benefits and drawbacks of flexible dosing with students and be willing to offer appropriate guidance and advice [ 184 , 185 ].

Non-pharmacological interventions

The view of the expert group is that non-pharmacological interventions are particularly important for university students who want or need to learn how to best manage their ADHD and overcome the learning difficulties that they experience. Medication alone maybe sufficient for a subgroup of university students, but persistent difficulties are more often seen, and additional support maybe required. Non-pharmacological interventions begin with psychoeducation. The experience of the expert group is that newly diagnosed students are keen to have a conversation about their diagnosis, including whether or not to disclose it to academic staff or future employers, the benefits, and drawbacks of taking medication, including flexible dosing, “drug holidays”, effects of medication on alcohol or other drugs, the positive attributes of ADHD (e.g., creativity), psychological interventions and reasonable adjustments. Research about the effectiveness of non-pharmacological interventions for adults with ADHD is mixed and inconclusive, but positive effects have been reported for mindfulness on core symptoms of ADHD including mind wandering [ 186 ], dialectical behaviour therapy (DBT) and cognitive behavioural therapy (CBT) [ 187 , 188 , 189 ].

Although research about non-pharmacological interventions for university students with ADHD is limited, new studies have been published. For instance, Anastopoulos et al. [ 190 ] and Eddy et al. [ 191 ] reported on the findings of a randomised controlled trial (RCT) that examined the efficacy of a CBT based program called ACCESS (Accessing Campus Connections and Empowering Student Success) for university students with ADHD. During the ACCESS program - psychoeducation, cognitive and behavioural strategies targeting executive function (EF) and patterns of maladaptive thinking, were delivered. Participants, who met DSM-5 diagnostic criteria for ADHD and were taking medication, were recruited from two large public universities in the USA and randomly assigned to either the ACCESS program group ( n  = 119) or a Delayed Treatment Control (DTC) group ( n  = 131). The findings revealed that the ACCESS program group participants self-reported significant improvements in their knowledge of ADHD, symptoms of inattention, EF, utilisation of disability accommodations (or reasonable adjustments), as well as a moderate decline in maladaptive thinking, when compared to DTC group participants. However, neither ACCESS program and DTC group participants reported significant improvements in their interpersonal functioning and educational outcomes (grade point average/GPA and course grade completion). The authors concluded that the ACCESS program made a large difference to the participants core symptoms of ADHD and EF.

Indeed, as noted previously, EF deficits have been shown to mediate the association between ADHD and impairments in academic functioning [ 100 ]. The finding that the ACCESS program positively impacted on the participants EF is therefore encouraging. It also supports the findings of an earlier pilot study about a CBT based group intervention to enhance EF functioning in university students with ADHD [ 172 ], and strengthens a more recent finding about how steep temporal discounting may play a key role in the daily life challenges that university students with ADHD encounter. Temporal discounting (TD) describes how the subjective value of a reward significantly declines when the said reward is delayed [ 192 ]. In a pilot study by Scheres and Solanto [ 193 ], steep TD was not only associated with combined type ADHD, specifically the hyperactivity-impulsivity symptom domain, but also with poor utilisation of learning and/or study skills. TD was therefore postulated to be an important target for EF interventions for university students with or without ADHD [ 193 ], more so for interventions that were designed to activate and sustain motivation to pursue a long-term goal for a reward, such as pursuing and completing a university degree [ 194 ]. Findings like this could be useful for enhancing the effectiveness of CBT based interventions for university students with ADHD like the ACCESS program, by for example, tailoring EF interventions to also target TD. Maybe this could improve educational outcomes and perhaps interpersonal functioning of university students with ADHD, which in the study reported by Anastopoulos et al. [ 190 ] showed no significant improvements.

The report that the ACCESS program made a large difference to the students’ core symptoms of ADHD, seems to contradict what the World Federation of ADHD international consensus statement acknowledged about good treatments for ADHD being available, but even the best treatments are only partially effective [ 164 ]. Overall, there is only low-quality evidence that CBT interventions might be beneficial for treating core symptoms of ADHD in adults, in the short-term, or for improving co-occurring symptoms of anxiety and depression [ 164 , 195 ]. It was noted by Anastopoulos et al., [ 190 ], that participants in both study groups increased their use of ADHD medications over the course of the study. Perhaps this was the real reason that the participants core symptoms of ADHD improved. After all, this is what ADHD medications are designed to do and treatments for ADHD usually become more effective when medication is combined with a CBT intervention [ 195 ], or when multimodal interventions are used [ 196 ].

Hence academic coaching, which tends to be a derivative of CBT, could be another useful intervention for optimising coping strategies in university students with ADHD. For instance, coaching has been used to help identify study goals, develop study plans and strategies for achieving these plans, monitoring their progress towards attaining them and to foster self-determination [ 197 ]. In one study, academic coaches helped university students with ADHD to develop better time management, organisational skills, pay more attention in classes and to take good notes, and improvements in these skills were observed after 8 weeks [ 198 ]. In another study, university students with ADHD reported that academic coaching had helped to enhance their self-discipline, self-efficacy, study skills, ability to formulate realistic goals and to think more about long-term goals and maintain motivation to achieve them [ 199 ]. Additional benefits of coaching can be in helping university students with ADHD feel more in control of their emotions and behaviours in the face of external demands [ 200 ]. Academic coaching (or specialist mentoring, or specialist one-to-one study skills support), can also be funded via DSA as specialist access and learning facilitators (Band 4). Academic coaching, supportive counselling and/or CBT, whether delivered face-to-face or online can be effective non-pharmacological interventions for university students with ADHD [ 188 , 189 , 201 ], and the potential of these interventions to improve academic performance is evident in the promising results of recent studies e.g. [ 172 , 190 ].

Recommendation 7. Multimodal interventions

The expert group recommends multimodal interventions for university students with ADHD, that comprise a variety of interventions including environmental modifications, psychoeducation, medication, academic coaching, DBT, CBT, counselling and/or mindfulness-based interventions. University counselling and disability services do tend to offer a range of psychosocial interventions for students, whether delivered online, face-to-face or in a group.

What are the staff training and developmental needs?

In the Institute for Employment Studies report to the Office for Students, practitioners working in university disability services identified a need for training and development to enable them to both support university students with ADHD and the academic staff working with them [ 52 ]. The SpLD Assessments and Standards Committee (SASC) [ 167 ], also recommended that practitioner psychologists and specialist teacher assessors require appropriate training to identify “ specific learning difficulties and patterns of behaviour that together would strongly suggest that a student has ADHD ” (p.11). The need for staff training and development was discussed during the consensus meeting, and it included training in how to liaise with and refer university students with ADHD to a suitably qualified practitioner for a diagnostic assessment (e.g., a psychiatrist, mental health nurse/ pharmacist non-medical prescriber). Practitioners and assessors seemed keen to receive “certified training” as a way to achieve the SASC recommendations for “appropriate training”. A certified educational programme about ADHD at university level 6 or 7, could be developed and delivered for example online, as a post-qualification professional training or continuous professional development (CPD). But at present, no such course/programme exists in the UK. UKAAN offers training for healthcare professionals and can deliver bespoke training to practitioners and assessors who work with university students, and some disability services have already done so. During the consensus meeting some practitioners and assessors said they often gained relevant experience by having previously worked, or currently working, with university students with ADHD or through their own personal lived experiences, and that they made use of these experiences in their role.

Recommendation 8. Training and development

The expert group recommends that staff training, and development be prioritised under the inclusive practice agenda in higher education. This training should include psychoeducation, procedures for screening and assessing for ADHD, and useful strategies for supporting university students with ADHD. This will enhance the knowledge and skills of practitioners and assessors who work with and/or support university students with ADHD.

Discussion & conclusion

This was a report of the UKAAN expert consensus meeting about university students with ADHD, which was held before the COVID-19 pandemic. Since then, the pandemic has altered higher education in a monumental way. When lockdown was first imposed in the UK, university campuses were suddenly closed. Students and staff had to quickly adapt to online delivery of lectures and classes, and there was uncertainty about being able to access digital technologies and quite places to study or work at home. There was also confusion among students about study expectations, assessments, workloads, retention, and completion [ 202 , 203 , 204 ]. Undoubtedly the pandemic has caused much suffering, frustration, fear, loss and other negative thoughts, emotions, and experiences for many people, including university students with ADHD [ 205 ]. However, findings about the impact of the pandemic on university students has been mixed. Frampton and Smithies [ 206 ], reported on a Students Minds survey about life during the pandemic involving 1100 university students. The findings of this survey revealed that 74% of respondents reported that the pandemic had a negative impact on their mental health and wellbeing, whilst only 10% of respondents reported positive effects. In this survey, disabled and non-disabled students were also asked whether they agreed or disagreed with the statement “ online learning has allowed me to engage with my course more positively ”, and the findings revealed that 59% of disabled students compared with 55% of non-disabled students disagreed with the statement. This also suggests that just under-half of these students agreed with the statement. In another study, 79 university students in one Faculty of Life Sciences were surveyed and participated in focus groups about how they experienced the sudden shift to online learning during the lockdown [ 207 ]. This study found that 75% of the students who participated in the study, reported that their life had become more difficult and 50% reported that learning outcomes would be hard to achieve, but after 12 weeks into the lockdown, corresponding rates changed to 57 and 71% respectively [ 207 ].

The findings of existing studies do suggest that during the COVID-19 lockdown, virtual learning for some university students may have had benefits such as enabling greater attendance, engagement, and participation in teaching sessions, especially for students who previously felt anxious about asking questions in front of others or some disabled students [ 202 ]. Students who were used to spending time online – on the Internet including social media platforms for example, seemed to exhibit strong motivation for eLearning, and reported lower levels of distress during the pandemic [ 208 ]. However, there are also concerning reports about ADHD being a risk factor for COVID-19 infection [ 209 , 210 ]. These reports are perhaps pertinent for university students with ADHD who may have participated in demonstrations during the pandemic such as Black Lives Matter (BLM), living arrangements in student halls of residence, sexual harassment, assault and “rape culture” in UK universities [ 206 , 211 ], or illegal COVID raves [ 212 ], or the COVID anti-vaccine and lockdown protests [ 213 ]. It can be argued that the pandemic may have longer-term negative consequences on current and future career prospects for university students with ADHD, but outside of this, no firm conclusions from the existing research can be drawn.

Evidence is stronger for poor education (or academic) performance and achievement having a long-term negative impact on mental health, wellbeing, and socio-economic outcomes [ 214 ]. Even though there is a paucity of research about university students with ADHD in the UK and rest of Europe, the importance of attending to the mental health of university students in the UK has been recognised. The Royal College of Psychiatrists recently published a college report on the mental health of higher education students, and Sedgwick-Müller et al., contributed a section on ADHD in this report [ 1 ]. The expert group is also aware that ADHD is a hidden disability within UK HEIs and its categorisation as a SpLD may be contributing to this, therefore university students with ADHD continue to be at risk of marginalisation and disadvantage. The expert group recommends that ADHD should be catered for under a separate category within UK HEIs, as this may enable greater recognition of ADHD and for its impact on learning within higher education to be adequately assessed and mitigated. With aspirations towards widening participation and inclusive practices in higher education [ 52 ], understanding exactly “what works” best for university students with ADHD is imperative. The four key stages in a student’s lifecycle are access to higher education (the extent to which students can gain entrance to different types of HEIs), retention (the likelihood of continuing or withdrawing from a programme of studies), attainment (the extent to which university students are enabled to achieve their full academic potential) , and progression (successful transitions within a programme of studies and afterwards into employment or further study )” [ 215 ], p.5). Each of these 4 key stages in a student’s lifecycle can be adversely affected by either having and/or not recognising ADHD, and by delaying access to a screening, diagnostic assessment, treatment, and educational support. Interventions in a student’s first year at university, according to Clery and Topper, should focus on enhancing their academic achievement because retention, attainment, and progression tends to be more favourable for university students who perform well academically in their first year [ 216 ].

In summary, UKAAN convened an expert consensus meeting to provide an informed understanding about the impact of ADHD on the educational (or academic) outcomes of university students and to highlight an urgent need for timely access to treatment and management. An overview of key issues, as well as expert advice and guidance has been offered. In Table 10 below, the main recommendations of the expert group are summarised. There is little doubt that university students with ADHD are struggling with long delays in accessing a diagnostic assessment, treatment, and personalised educational support. The provision of rapid access treatment and care pathways can be challenging for clinicians working in specialist NHS ADHD clinics, but examples of good practice are also beginning to emerge, with some university disability services drawing on their own budgets to support their students. Further work is needed to develop and evaluate efficient and cost-effective treatment and care pathways for university students with ADHD (for example see Fig. 4 ), and to adopt models of best practice across the sector. University students, including those with ADHD, are at a crucial transitioning stage in life and their success at university is likely to determine their success in highly competitive employment markets. This strengthens the argument to support all university students in an inclusive manner. Methods for inclusive teaching and learning are also likely to cater to disabled students, including university students with ADHD.

Availability of data and materials

Data sharing is not applicable to this article as no data sets were generated or analysed during the study.

Abbreviations

ADHD Child Evaluation

Association for Higher Access & Disability

Attention Deficit Hyperactivity Disorder

American Psychiatric Association

Autism-Spectrum Quotient

Autism Spectrum Disorder

Adult ADHD Self-report Rating Scale

Canadian ADHD Practice Guidelines

Cognitive Behavioural Therapy

Diagnostic Interview for ADHD in adults

Dialectical Behavioural Therapy

Disabled Students Allowance

Developmental co-ordination disorder

Diagnostic and Statistical Manual of Mental Disorders version 5

Emotional lability

Executive Functions

Institutions of Higher Education

The Higher Education Statistical Authority

Improving Access to Psychological Therapies

Institute of Employment Studies

Major Depressive Disorder

Math Disability

National Health Service

National Institute for Health and Care Excellence

Office for Students

Panic Disorders Severity Scale

Patient Health Questionnaire

Processing Speed

Penn State Worry Questionnaire

Quantified Behavior Test

Reding Disability

Special Educational Needs and Disabilities

Special Educational Needs

Specific Learning Disorders

SpLD Assessment and Standards Committee

Specific learning differences

The Simple Screening Instrument for Substance Abuse

UK Adult ADHD Network

United Kingdom of Great Britain and Northern Ireland

Wechsler Adult Intelligence Scale

Weiss Functional Impairment Rating Scale – Self Report

World Health Organisation

Working Memory

Writing Disability

The Royal College of Psychiatrists: Mental Health of Higher Education Students [College Report CR23]. London.

Arnett J. Emerging adulthood: the winding road from the late teens through the twenties. New York, NY: Oxford University Press; 2014.

Book   Google Scholar  

Arnett J. College students as emerging adults: the developmental implications of the college context. Emerg Adulthood. 2015;4(3):219–22.

Article   Google Scholar  

MacLeod KB, Brownlie EB. Mental health and transitions from adolescence to emerging adulthood: developmental and diversity considerations. Can J Community Ment Health. 2014;33(1):77–86.

Universities-UK. Minding our future: starting a conversation about the support of student mental health. London; 2018.

American Psychiatric Association. Diagnostic and statistical manual of mental disorders (DSM). 5th ed; 2013.

World Health Organisation (WHO). International classification of diseases (ICD). 11th ed. Geneva; 2019.

Czamara D, Tiesler CM, Kohlböck G, Berdel D, Hoffmann B, Bauer C-P, et al. Children with ADHD symptoms have a higher risk for reading, spelling and math difficulties in the GINIplus and LISAplus cohort studies. PLoS One. 2013;8(5):e63859.

Article   CAS   PubMed   PubMed Central   Google Scholar  

Davis NO, Kollins SH. Treatment for co-occurring attention deficit/hyperactivity disorder and autism spectrum disorder. Neurotherapeutics. 2012;9(3):518–30.

Fayyad J, Sampson NA, Hwang I, Adamowski T, Aguilar-Gaxiola S, Al-Hamzawi A, et al. The descriptive epidemiology of DSM-IV adult ADHD in the World Health Organization world mental health surveys. Atten Defic Hyperact Disord. 2017;9(1):47–65.

Article   PubMed   Google Scholar  

Germanò E, Gagliano A, Curatolo P. Comorbidity of ADHD and dyslexia. Dev Neuropsychol. 2010;35(5):475–93.

Kessler RC, Adler L, Barkley R, Biederman J, Conners CK, Demler O, et al. The prevalence and correlates of adult ADHD in the United States: results from the National Comorbidity Survey Replication. Am J Psychiatr. 2006;163(4):716–23.

Wadsworth SJ, DeFries JC, Willcutt EG, Pennington BF, Olson RK. Genetic etiologies of comorbidity and stability for Reading difficulties and ADHD: a replication study. Twin Res Hum Genet. 2016;19(6):647–51.

Article   PubMed   PubMed Central   Google Scholar  

Yoshimasu K, Barbaresi WJ, Colligan RC, Killian JM, Voigt RG, Weaver AL, et al. Written-language disorder among children with and without ADHD in a population-based birth cohort. Pediatrics. 2011;128(3):e605–12.

Langberg JM, Becker SP. ADHD treatment and long-term academic outcomes: response to Arnold and Colleagues. J Atten Disord. 2015;24(5):819–20.

Anastopoulos A, DuPaul G, Weyandt L, Morrissey-Kane E, Sommer J, Rhoads L, et al. Rates and patterns of comorbidity among first-year college students with ADHD. J Clin Child Adolesc Psychol. 2018;47(2):236–47.

Langberg JM, Molina BSG, Arnold LE, Epstein JN, Altaye M, Hinshaw SP, et al. Patterns and predictors of adolescent academic achievement and performance in a sample of children with attention-deficit/hyperactivity disorder. J Clin Child Adolesc Psychol. 2011;40(4):519–31.

Arnold L, Hodgkins P, Kahle J, Madhoo M. G K: long-term outcomes of ADHD: academic achievement and performance. J Atten Disord. 2015;24(1):73–85.

Asherson P, Buitelaar J, Faraone S, Rohde L. Adult attention-deficit hyperactivity disorder: key conceptual issues. Lancet Psychiatry. 2016;3(6):568–78.

Nigg JT. Attention-deficit/hyperactivity disorder and adverse health outcomes. Clin Psychol Rev. 2013;33(2):215–28.

Sedgwick J. University students with attention deficit hyperactivity disorder (ADHD): a literature review. Ir J Psychol Med. 2018;35(3):221–35.

Article   CAS   PubMed   Google Scholar  

Higher Education Statistical Agency (HESA), UK-domiciled student enrolments by disability and sex: For the academic years 2014/15–2018/19 at: https://www.hesa.ac.uk/data-and-analysis/students/table-15 . Accessed 31 July 2021.

Department for Education Department of Health. The special educational needs and disability (SEND) code of practice 0–25 years. London: HMSO; 2015.

Google Scholar  

Hinshaw S, Scheffler R. The ADHD explosion: myths, medication, money, and Today’s push for performance vol. 67. New York: Oxford University Press; 2014.

Midgley H. Payment by results in nineteenth-century British education: a study in how priorities change. J Policy Hist. 2016;28(4):680–706.

Newcastle, Duke of. [The Newcastle Commission]. Report of the Royal Commissioners appointed to inquire into the state of popular education in England, vol. 1. London: HMSO; 1861.

Potts P. Medicine, morals and mental deficiency: the contribution of doctors to the development of special education in England. Oxf Rev Educ. 1983;9(3):181–96.

Copeland IC. The establishment of models of education for disabled children. Br J Educ Stud. 1995;43(2):179–200.

Ross D, Ross S. Hyperactivity: research, theory, and action. New York: Wiley; 1976.

The Egerton Royal Commission. Report of the Royal Commission on the blind, the deaf and dumb & c., of the United Kingdom. London: HMSO; 1889.

Petrina S. The medicalization of education: a Historiographic synthesis. Hist Educ Q. 2006;46(4):503–31.

Still G. The Goulstonian lectures ON SOME ABNORMAL PSYCHICAL CONDITIONS IN CHILDREN. Lancet. 1902;159(4102):1008–13.

Lange KW, Reichl S, Lange KM, Tucha L, Tucha O. The history of attention deficit hyperactivity disorder. Atten Defic Hyperact Disord. 2010;2(4):241–55.

British Medical Journal. Report of the Departmental Committee on Defective and Epileptic Children. 1940;1898(1):651–2.

Woodhouse J. Eugenics and the feeble-minded: the parliamentary debates of 1912-14. Hist Educ. 1982;11(2):127–37.

Binet A, Simon T. Méthodes nouvelles pour diagnostiquer l'idiotie, l’imbécillité et la débilité mentale [New methods for the diagnosis of the intellectual level of abnormal children to diagnose the idiocy, the imbecility, and the mental deficiency]. Atti del V congresso internazionale di psicologia tenuto in Roma dal 26 al 30 Aprile; 1905.

Binet A, Simon T. Le développement de l'intelligence chez les enfants. L'année Psychol. 1907;14(1):1–94.

Spearman C. "general intelligence," objectively determined and measured. Am J Psychol. 1904;15(2):201.

Radnor Report. Report of the Royal Commission on the care and control of the feeble-minded, VIII, cd 4202. London: HMSO; 1908.

Hearnshaw L. Cyril Burt: psychologist. Ithaca: Cornell University Press; 1979.

Burt C. Mental and scholastic tests (London County council). London: P.S. King and Son; 1922.

Burt C. The causal factors of juvenile crime. Br J Med Psychol. 1923;3(1):9–33.

Burt C. The Young delinquent, First edn. London: University of London Press; 1925.

Burt C. The backward child. London: University of London Press; 1937.

Bradley C. The behavior of children receiving benzedrine. Am J Psychiatr. 1937;94(3):577–85.

Lindsay G, Miller A. Psychological Services for Primary Schools. Harlow, Essex: UK; 1991.

Warnock H. Warnock Report of the Committee of Enquiry into the education of handicapped children and Young people. London; 1978.

Thorley G. Hyperkinetic syndrome of childhood: clinical characteristics. Br J Psychiatry. 1984;144(1):16–24.

Hill P, Taylor E. An auditable protocol for treating attention deficit/hyperactivity disorder. Arch Dis Child. 2001;84(5):404–9.

NICE (National Institute for Health and Care Excellence). Attention deficit hyperactivity disorder: diagnosis and management, vol. 2018. London; 2008.

Ewe LP. ADHD symptoms and the teacher–student relationship: a systematic literature review. Emot Behav Diffic. 2019;24(2):136–55.

Williams M, Pollard E, Takala H, Houghton A-M. Review of Support for Disabled Students in Higher Education in England. Brighton: Office for Students; 2019.

Reis SM, Renzulli JS. Intellectual Giftedness. In: Stenberg RJ, editor. The Cambridge Handbook of Intelligence: Cambridge University Press; 2020. p. 291–316.

Sternberg RJ. The Augmented Theory of Successful Intelligence. In: Sternberg RJ, editor. The Cambridge Handbook of Intelligence: Cambridge University Press; 2020. p. 679–708.

Sternberg R, Davidson J. Conceptions of giftedness, vol. 2005. Cambridge: Cambridge University Press; 1986.

von Stumm S, Hell B, Chamorro-Premuzic T. The hungry mind. Perspect Psychol Sci. 2011;6(6):574–88.

Canadian ADHD. Resource Alliance (CADDRA): Canadian ADHD practice guidelines., 4th edn. Canada.

Antshel K, Faraone S, Stallone K, Nave A, Kaufmann F, Doyle A, et al. Is attention deficit hyperactivity disorder a valid diagnosis in the presence of high IQ? Results from the MGH longitudinal family studies of ADHD. J Child Psychol Psychiatry. 2007;48(7):687–94.

Antshel K. Attention-deficit hyperactivity disorder in the context of a high intellectual quotient/giftedness. Dev Disabil Res Rev. 2008;14(4):293–9.

Barkley R, Poillion M. Attention deficit hyperactivity disorder: a handbook for diagnosis and treatment. New York: The Guildford Press; 1990.

Beljan P, Webb J, Amend E, Web N, Goerss J, Olenchak F. Misdiagnosis and dual diagnoses of gifted children and adults: ADHD, bipolar, OCD, Asperger’s, depression, and other disorders. Gifted Talented Int. 2006;21(2):83–6.

Rinn AN, Reynolds MJ. Overexcitabilities and ADHD in the gifted: an examination. Roeper Rev. 2012;34(1):38–45.

Dabrowski K. Positive Disintegration. Boston: Little, Brown; 1964.

Silverman LK. The construct of asynchronous development. Peabody J Educ. 1997;72(3):36–58.

Mullet DR, Rinn AN. Giftedness and ADHD: identification, misdiagnosis, and dual diagnosis. Roeper Rev. 2015;37(4):195–207.

Brown T, Reichel P, Quinlan D. Executive function impairments in high IQ adults with ADHD. J Atten Disord. 2009;13(2):161–7.

Minahim D, Rohde LA. Attention deficit hyperactivity disorder and intellectual giftedness: a study of symptom frequency and minor physical anomalies. Rev Bras Psiquiatr. 2015;37(4):289–95.

Milioni ALV, Chaim TM, Cavallet M, de Oliveira NM, Annes M, dos Santos B, et al. High IQ may “mask” the diagnosis of ADHD by compensating for deficits in executive functions in treatment-Naïve adults with ADHD. J Atten Disord. 2016;21(6):455–64.

Gomez R, Stavropoulos V, Vance A, Griffiths MD. Gifted children with ADHD: how are they different from non-gifted children with ADHD? Int J Ment Heal Addict. 2019;18(6):1467–81.

Baron-Cohen S, Ashwin E, Ashwin C, Tavassoli T, Chakrabrati B. Talent in autism: hyper-systemizing, hyper-attention to detail and sensory hypersensitivity. Philos Trans R Soc Lond Ser B Biol Sci. 2009;364(1522):1377–83.

Ruthsatz J, Urbach JB. Child prodigy: a novel cognitive profile places elevated general intelligence, exceptional working memory and attention to detail at the root of prodigiousness. Intelligence. 2012;40(5):419–26.

Lee KM, Olenchak FR. Individuals with a gifted/attention deficit/hyperactivity disorder diagnosis. Gift Educ Int. 2014;31(3):185–99.

Antshel K, Faraone S, Maglione K, Doyle A, Fried R, Seidman L, et al. Executive functioning in high-IQ adults with ADHD. Psychol Med. 2010;40(11):1909–18.

Rommelse N, Antshel K, Smeets S, Greven C, Hoogeveen L, Faraone SV, et al. High intelligence and the risk of ADHD and other psychopathology. Br J Psychiatry. 2017;211(6):359–64.

Young S, Adamou M, Asherson P, Coghill D, Colley B, Gudjonsson G, et al. Recommendations for the transition of patients with ADHD from child to adult healthcare services: a consensus statement from the UK adult ADHD network. BMC Psychiatry. 2016;16(1):301.

Jensen M. Personality traits, learning and academic achievements. J Educ Learn. 2015;4(4):91.

Rimfeld K, Ayorech Z, Dale PS, Kovas Y, Plomin R. Genetics affects choice of academic subjects as well as achievement. Sci Rep. 2016;6:26373.

Arksey H, O’Malley L. Scoping studies: towards a methodological framework. Int J Soc Res Methodol. 2005;8(1):19–32.

Nutt DJ, Fone K, Asherson P, Bramble D, Hill P, Matthews K, et al. Evidence-based guidelines for management of attention-deficit/hyperactivity disorder in adolescents in transition to adult services and in adults: recommendations from the British Association for Psychopharmacology. J Psychopharmacol. 2006;21(1):10–41.

Bolea-Alamañac B, Nutt DJ, Adamou M, Asherson P, Bazire S, Coghill D, et al. Evidence-based guidelines for the pharmacological management of attention deficit hyperactivity disorder: update on recommendations from the British Association for Psychopharmacology. J Psychopharmacol (Oxford, England). 2014;28(3):179–203.

Husserl E. Ideas pertaining to a pure phenomenology and to a phenomenological philosophy. Netherlands: Springer; 1982.

Giorgi A. The theory, practice, and evaluation of the phenomenological method as a qualitative research procedure. J Phenomenol Psychol. 1997;28(2):235–60.

Pope D, Whiteley H, Smith C, Lever R, Wakelin D, Dudiak H, et al. Relationships between ADHD and dyslexia screening scores and academic performance in undergraduate psychology students: implications for teaching, learning and assessment. Psychol Learn Teach. 2007;6(2):114–20.

DuPaul GJ, Weyandt LL, O'Dell SM, Varejao M. College students with ADHD: current status and future directions. J Atten Disord. 2009;13(3):234–50.

Norvilitis JM, Ingersoll T, Jie Z, Shuhua J. Self-reported symptoms of ADHD among college students in China and the United States. J Atten Disord. 2007;11(5):558–67.

Du Rietz E, Cheung CHM, McLoughlin G, Brandeis D, Banaschewski T, Asherson P, et al. Self-report of ADHD shows limited agreement with objective markers of persistence and remittance. J Psychiatr Res. 2016;82:91–9.

Connell-Smith A, Hubble S. Widening participation strategy in higher education in England. London: House of Commons Library; 2018.

Association for Higher Education Access and Disability (AHEAD). Numbers of Students with Disabilities Studying in Higher Education in Ireland 2017/18. Dublin: AHEAD Educational Press; 2019.

Cortese S, Adamo N, Del Giovane C, Mohr-Jensen C, Hayes AJ, Carucci S, et al. Comparative efficacy and tolerability of medications for attention-deficit hyperactivity disorder in children, adolescents, and adults: a systematic review and network meta-analysis. Lancet Psychiatry. 2018;5(9):727–38.

Fullen T, Jones SL, Emerson LM, Adamou M. Psychological treatments in adult ADHD: a systematic review. J Psychopathol Behav Assess. 2020;42(3):500–18.

Snowling MJ, Hulme C. Annual research review: the nature and classification of reading disorders--a commentary on proposals for DSM-5. J Child Psychol Psychiatry. 2012;53(5):593–607.

Gialluisi A, Andlauer TFM, Mirza-Schreiber N, Moll K, Hoffmann P, Ludwig KU, et al. Genome wide association scan identifies new variants associated with a cognitive predictor of dyslexia. Transl Psychiatry. 2018;9(77):1–15.

Dighe A, Kettles G. Developmental dyspraxia an overview. In: Reid G, editor. Dimensions of Dsylexia: assessment, teaching and the curriculum, vol. 2. Edinburgh, Scotland: Moray House School of Education; 1996.

Hosenbocus S, Chahal R. A review of executive function deficits and pharmacological management in children and adolescents. J Can Acad Child Adolesc Psychiatry. 2012;21(3):223–9.

PubMed   PubMed Central   Google Scholar  

Diamond A. Executive functions. Annu Rev Psychol. 2013;64:135–68.

Friedman NP, Miyake A. Unity and diversity of executive functions: individual differences as a window on cognitive structure. Cortex. 2017;86:186–204.

Barkley R. Differential diagnosis of adults with ADHD: the role of executive function and self-regulation. J Clin Psychiatry. 2010;71(07):e17.

Brown T. Executive functions and attention deficit hyperactivity disorder: implications of two conflicting views. Int J Disabil Dev Educ. 2006;53(1):35–46.

Brown T. ADD/ADHD and impaired executive function in clinical practice. Curr Psychiatry Rep. 2008;10(5):407–11.

Dvorsky MR, Langberg JM. Predicting impairment in college students with ADHD: the role of executive functions. J Atten Disord. 2014;23(13):1624–36.

Hervey AS, Epstein JN, Curry JF. Neuropsychology of adults with attention-deficit/hyperactivity disorder: a Meta-analytic review. Neuropsychology. 2004;18(3):485–503.

Shanahan MA, Pennington BF, Yerys BE, Scott A, Boada R, Willcutt EG, et al. Processing speed deficits in attention deficit/hyperactivity disorder and Reading disability. J Abnorm Child Psychol. 2006;34(5):584–601.

Willcutt EG, Pennington BF, Olson RK, Chhabildas N, Hulslander J. Neuropsychological Analyses of Comorbidity Between Reading Disability and Attention Deficit Hyperactivity Disorder: In Search of the Common Deficit. Dev Neuropsychol. 2005;27(1):35–78.

Rose J. Identifying and teaching children and Young people with dyslexia and literacy difficulties: an independent Report. London: Department for Children, Schools and Families (DCSF); 2009.

Schwenk C, Sasanguie D, Kuhn J-T, Kempe S, Doebler P, Holling H. (non-)symbolic magnitude processing in children with mathematical difficulties: a meta-analysis. Res Dev Disabil. 2017;64:152–67.

Harrowell I, Hollén L, Lingam R, Emond A. The impact of developmental coordination disorder on educational achievement in secondary school. Res Dev Disabil. 2018;72:13–22.

Baddeley A, Hitch G. Working Memory. In: Bower G, editor. Psychology of Learning and Motivation, vol. 8. New York: Academic; 1974. p. 47–89.

Baddeley A. Exploring the central executive. Q J Exp Psychol A. 1996;49(1):5–28.

Baddeley A. The episodic buffer: a new component of working memory? Trends Cogn Sci. 2000;4(11):417–23.

Baddeley A. Working memory, thought, and action: Oxford University Press; 2007.

Baddeley A. Working memory: theories, models, and controversies. Annu Rev Psychol. 2012;63(1):1–29.

Schubert A-L, Hagemann D, Löffler C, Frischkorn GT. Disentangling the effects of processing speed on the association between age differences and fluid intelligence. J Intell. 2019;8(1):1.

Article   PubMed Central   Google Scholar  

Jensen A. Clocking the mind: mental chronometry and individual differences. 1st ed. Amsterdam: Elsevier Science Ltd; 2006.

Mayes SD, Calhoun SL. Learning, attention, writing, and processing speed in typical children and children with ADHD, autism, anxiety, depression, and oppositional-defiant disorder. Child Neuropsychol. 2007;13(6):469–93.

Braaten E, Wiloughby B. Bright kids who can't keep up. New York: The Guilford Press; 2014.

McGrath LM, Pennington BF, Shanahan MA, Santerre-Lemmon LE, Barnard HD, Willcutt EG, et al. A multiple deficit model of reading disability and attention-deficit/hyperactivity disorder: searching for shared cognitive deficits. J Child Psychol Psychiatry. 2011;52(5):547–57.

Boada R, Willcutt E, Pennington B. Understanding the comorbidity between dyslexia and attention-deficit/hyperactivity disorder. Top Lang Disord. 2012;32(3):264–84.

DuPaul GJ, Gormley MJ, Laracy SD. Comorbidity of LD and ADHD: implications of DSM-5 for assessment and treatment. J Learn Disabil. 2012;46(1):43–51.

Lane SJ, Reynolds S. Sensory over-Responsivity as an added dimension in ADHD. Front Integr Neurosci. 2019;13:40.

Marco EJ, Hinkley LBN, Hill SS, Nagarajan SS. Sensory processing in autism: a review of neurophysiologic findings. Pediatr Res. 2011;69(5 Pt 2):48R–54R.

Stray LL, Kristensen Ø, Lomeland M, Skorstad M, Stray T, Tønnessen FE. Motor regulation problems and pain in adults diagnosed with ADHD. Behav Brain Funct. 2013;9(18):1–10.

Kessler RC, Adler L, Ames M, Demler O, Faraone S, Hiripi EVA, et al. The World Health Organization adult ADHD self-report scale (ASRS): a short screening scale for use in the general population. Psychol Med. 2005;35(2):245–56.

Allison C, Auyeung B, Baron-Cohen S. Toward brief “red flags” for autism screening: the short autism Spectrum quotient and the short quantitative checklist in 1,000 cases and 3,000 controls. J Am Acad Child Adolesc Psychiatry. 2012;51(2):202–212.e207.

British Dyslexia Association (BDA): The Adult Dyslexia Checklist, at: https://www.bdadyslexia.org.uk/dyslexia/how-is-dyslexia-diagnosed/dyslexia-checklists , Accessed 31 July 2021.

Kessler RC, Andrews G, Colpe LJ, Hiripi E, Mroczek DK, Normand SLT, et al. Short screening scales to monitor population prevalences and trends in non-specific psychological distress. Psychol Med. 2002;32(6):959–76.

Meyer TJ, Miller ML, Metzger RL, Borkovec TD. Development and validation of the penn state worry questionnaire. Behav Res Ther. 1990;28(6):487–95.

Centre for Substance Abuse Treatment. Substance Abuse Treatment for Persons with Co-occurring Disorders, Treatment Improvement Protocol (TIP) Series 42, Appendix H: Screening Instruments. Rockville: Substance Abuse and Mental Health Services Administration; 1994.

The National Collaborating Centre for Mental Health: The Improving Access to Psychological Therapies Manual, Updated August 2021, at: https://www.england.nhs.uk/publication/the-improving-access-to-psychological-therapies-manual/ . London, UK; 2018.

DIVA Foundation: The Diagnostic Interview for ADHD in Adults (DIVA-5), at: https://www.divacenter.eu/DIVA.aspx?id=523; 2019.

Young S, Gudjonsson GH. Growing out of ADHD. J Atten Disord. 2007;12(2):162–9.

Weiss MD. Weiss functional impairment rating scale (WFIRS) self-Report. Vancouver: University of British Columbia; 2000.

Mahdi S, Viljoen M, Massuti R, Selb M, Almodayfer O, Karande S, et al. An international qualitative study of ability and disability in ADHD using the WHO-ICF framework. Eur Child Adolesc Psychiatry. 2017;26(10):1219–31.

Sedgwick JA, Merwood A, Asherson P. The positive aspects of attention deficit hyperactivity disorder: a qualitative investigation of successful adults with ADHD. ADHD Atten Deficit Hyperactivity Disord. 2019;11(3):241–53.

Moss SB, Nair R, Vallarino A, Wang S. Attention deficit/hyperactivity disorder in adults. Prim Care. 2007;34(3):445–73.

Eysenck MW, Derakshan N, Santos R, Calvo MG. Anxiety and cognitive performance: Attentional control theory. Emotion. 2007;7(2):336–53.

Sparfeldt JR, Rost DH, Baumeister UM, Christ O. Test anxiety in written and oral examinations. Learn Individ Differ. 2013;24:198–203.

Zeidner M. Test anxiety: the state of the art. Boston: Springer; 1998.

Young S, Adamo N, Ásgeirsdóttir BB, Branney P, Beckett M, Colley W, et al. Females with ADHD: an expert consensus statement taking a lifespan approach providing guidance for the identification and treatment of attention-deficit/ hyperactivity disorder in girls and women. BMC Psychiatry. 2020;20(1):404.

Skirrow C, McLoughlin G, Kuntsi J, Asherson P. Behavioral, neurocognitive and treatment overlap between attention-deficit/hyperactivity disorder and mood instability. Expert Rev Neurother. 2009;9(4):489–503.

Skirrow C, Asherson P. Emotional lability, comorbidity and impairment in adults with attention-deficit hyperactivity disorder. J Affect Disord. 2013;147(1–3):80–6.

Vidal R, Valero S, Nogueira M, Palomar G, Corrales M, Richarte V, et al. Emotional lability: the discriminative value in the diagnosis of attention deficit/hyperactivity disorder in adults. Compr Psychiatry. 2014;55(7):1712–9.

Riley AW, Lyman LM, Spiel G, Döpfner M, Lorenzo MJ, Ralston** SJ: The family strain index (FSI). Reliability, validity, and factor structure of a brief questionnaire for families of children with ADHD. Eur Child Adolesc Psychiatry 2006, 15(S1):i72-i78.

Dougherty L. Children's emotionality and social status: a Meta-analytic review. Soc Dev. 2006;15(3):394–417.

Davidson RJ, Jackson DC, Kalin NH. Emotion, plasticity, context, and regulation: perspectives from affective neuroscience. Psychol Bull. 2000;126(6):890–909.

Yen J-Y, Ko C-H, Yen C-F, Wu H-Y, Yang M-J. The comorbid psychiatric symptoms of internet addiction: attention deficit and hyperactivity disorder (ADHD), depression, social phobia, and hostility. J Adolesc Health. 2007;41(1):93–8.

Breyer J, Botzet A, Winters K, Stinchfield R, August G, Realmuto G. Young adult gambling behaviors and their relationship with the persistence of ADHD. J Gambl Stud. 2009;25(2):227–38.

Baker L, Prevatt F, Proctor B. Drug and alcohol use in college students with and without ADHD. J Atten Disord. 2011;16(3):255–63.

Rooney M, Chronis-Tuscano A, Yoon Y. Substance use in college students with ADHD. J Atten Disord. 2011;16(3):221–34.

Arria A, Garnier-Dykstra L, Caldeira K, Vincent K, Winick E, O'Grady K. Drug use patterns and continuous enrollment in college: results from a longitudinal study. J Stud Alcohol Drugs. 2013;74(1):71–83.

Spera V, Pallucchini A, Carli M, Maiello M, Maremmani AGI, Perugi G, et al. Does Cannabis, cocaine and alcohol use impact differently on adult attention deficit/hyperactivity disorder clinical picture? J Clin Med. 2021;10(7):1481.

Cooper RE, Williams E, Seegobin S, Tye C, Kuntsi J, Asherson P. Cannabinoids in attention-deficit/hyperactivity disorder: a randomised-controlled trial. Eur Neuropsychopharmacol. 2017;27(8):795–808.

Carmona-Halty M, Schaufeli WB, Salanova M. Good relationships, good performance: the mediating role of psychological capital - a three-wave study among students. Front Psychol. 2019;10(306):1–5.

Dennis M, Francis DJ, Cirino PT, Schachar R, Barnes MA, Fletcher JM. Why IQ is not a covariate in cognitive studies of neurodevelopmental disorders. J Int Neuropsychol Soc. 2009;15(3):331–43.

Geertshuis SA. Slaves to our emotions: examining the predictive relationship between emotional well-being and academic outcomes. Act Learn High Educ. 2018;20(2):153–66.

Lewis M, Vance A, Maruff P, Wilson P, Cairney S. Differences in motor imagery between children with developmental coordination disorder with and without the combined type of ADHD. Dev Med Child Neurol. 2008;50(8):608–12.

Pekrun R, Goetz T, Perry RP, Kramer K, Hochstadt M, Molfenter S. Beyond test anxiety: development and validation of the test emotions questionnaire (TEQ). Anxiety Stress Coping. 2004;17(3):287–316.

Thornicroft G. Stigma and discrimination limit access to mental health care. Epidemiol Psichiatria Soc. 2008;17(1):14–9.

Kooij J, Bijlenga D, Salerno L, Jaeschke R, Bitter I, Balázs J, et al. Updated European consensus statement on diagnosis and treatment of adult ADHD. Eur Psychiatry. 2019;56(1):14–34.

Pescosolido BA, Martin JK, Lang A, Olafsdottir S. Rethinking theoretical approaches to stigma: a framework integrating normative influences on stigma (FINIS). Soc Sci Med. 2008;67(3):431–40.

Lebowitz MS. Stigmatization of ADHD. J Atten Disord. 2013;20(3):199–205.

Tatlow-Golden M, Prihodova L, Gavin B, Cullen W, McNicholas F. What do general practitioners know about ADHD? Attitudes and knowledge among first-contact gatekeepers: systematic narrative review. BMC Fam Pract. 2016;17(1):1–15.

Canu WH, Newman ML, Morrow TL, Pope DLW. Social appraisal of adult ADHD. J Atten Disord. 2007;11(6):700–10.

McKeague L, Hennessy E, O'Driscoll C, Heary C. Retrospective accounts of self-stigma experienced by young people with attention-deficit/hyperactivity disorder (ADHD) or depression. Psychiatr Rehabil J. 2015;38(2):158–63.

Faraone SV, Banaschewski T, Coghill D, Zheng Y, Biederman J, Bellgrove MA, et al. The world federation of ADHD international consensus statement: 208 evidence-based conclusions about the disorder. Neurosci Biobehav Rev. 2021;128:789–818.

Harrison A, Edwards M, Parker K. Identifying students faking ADHD: preliminary findings and strategies for detection. Arch Clin Neuropsychol. 2007;22(5):577–88.

Musso MW, Gouvier WD. “Why is this so hard?” a review of detection of malingered ADHD in college students. J Atten Disord. 2012;18(3):186–201.

SpLD Assessment and Standards Committee (SASC). Suitable tests for the assessment of specific learning difficulties in higher education, at: http://www.sasc.org.uk/(S(fre2zi45ou2m12vcc1nx43q0))/SASCDocuments/REVISED%20guidelines-March%202016.pdf . Accessed 31 July 2021. London; 2016.

Adler L, Spencer T, Levine L, Ramsey J, Tamura R, Kelsey D, et al. Diagnosing and treating adult ADHD and comorbid conditions. J Clin Psychiatry. 2008;69(11):e31.

NICE (National Institute for Health and Care Excellence). Common mental health problems: identification and pathways to care. London; 2011.

Denton CA, Tamm L, Schatschneider C, Epstein JN. The effects of ADHD treatment and Reading intervention on the fluency and comprehension of children with ADHD and word Reading difficulties: a randomized clinical trial. Sci Stud Read. 2020;24(1):72–89.

McLean A, Dowson J, Toone B, Young S, Bazanis E, Robbins TW, et al. Characteristic neurocognitive profile associated with adult attention-deficit/hyperactivity disorder. Psychol Med. 2004;34(4):681–92.

Solanto MV, Scheres A. Feasibility, acceptability, and effectiveness of a new cognitive-behavioral intervention for college students with ADHD. J Atten Disord. 2020;25(14):2068–82.

Barkley R. Neuropsychological testing is not useful in the diagnosis of ADHD: stop it (or prove it)! ADHD Rep. 2019;27(2):1–8.

Gioia GA, Isquith PK, Guy SC, Kenworthy L. Test review: behavior rating inventory of executive function. Child Neuropsychol. 2000;6(3):235–8.

Mowlem F, Agnew-Blais J, Taylor E, Asherson P. Do different factors influence whether girls versus boys meet ADHD diagnostic criteria? Sex differences among children with high ADHD symptoms. Psychiatry Res. 2019;272:765–73.

Faraone S, Kunwar A, Adamson J, Biederman J. Personality traits among ADHD adults: implications of late-onset and subthreshold diagnoses. Psychol Med. 2009;39(4):685–93.

Leucht S, Hierl S, Kissling W, Dold M, Davis JM. Putting the efficacy of psychiatric and general medicine medication into perspective: review of meta-analyses. Br J Psychiatry. 2012;200(2):97–106.

Rabiner DL, Anastopoulos AD, Costello EJ, Hoyle RH, McCabe SE, Swartzwelder HS. Motives and perceived consequences of nonmedical ADHD medication use by college students. J Atten Disord. 2008;13(3):259–70.

DuPaul GJ, Weyandt LL, Rossi JS, Vilardo BA, O’Dell SM, Carson KM, et al. Double-blind, placebo-controlled, crossover study of the efficacy and safety of Lisdexamfetamine Dimesylate in college students with ADHD. J Atten Disord. 2012;16(3):202–20.

Advokat C, Lane S, Luo C. College students with and without ADHD. J Atten Disord. 2010;15(8):656–66.

Lu Y, Sjölander A, Cederlöf M, D'Onofrio BM, Almqvist C, Larsson H, et al. Association between medication use and performance on higher education entrance tests in individuals with attention-deficit/hyperactivity disorder. JAMA Psychiatry. 2017;74(8):815–22.

Rabiner DL, Anastopoulos AD, Costello EJ, Hoyle RH, Esteban McCabe S, Swartzwelder HS. The misuse and diversion of prescribed ADHD medications by college students. J Atten Disord. 2009;13(2):144–53.

DeSantis AD, Webb EM, Noar SM. Illicit use of prescription ADHD medications on a college campus: a multimethodological approach. J Am Coll Heal. 2008;57(3):315–24.

Caisley H, Müller U. Adherence to medication in adults with attention deficit hyperactivity disorder and pro re nata dosing of psychostimulants: a systematic review. Eur Psychiatry. 2012;27(5):343–9.

Müller-Sedgwick U, Sedgwick-Müller JA. Drugs to treat attention deficit hyperactivity disorder (ADHD). In: Seminars in clinical psychopharmacology: Cambridge University Press; 2020. p. 392–432.

Cairncross M, Miller C. The effectiveness of mindfulness-based therapies for ADHD: a Meta-analytic review. J Atten Disord. 2016;24(5):627–43.

De Crescenzo F, Cortese S, Adamo N, Janiri L. Pharmacological and non-pharmacological treatment of adults with ADHD: a meta-review. Evid Based Ment Health. 2016;20(1):4–11.

Jensen CM, Amdisen BL, Jørgensen KJ, Arnfred SMH. Cognitive behavioural therapy for ADHD in adults: systematic review and meta-analyses. ADHD Atten Deficit Hyperactivity Disord. 2016;8(1):3–11.

Ramsay JR, Rostain AL. Cognitive-behavioral therapy for adult ADHD: Routledge; 2012.

Anastopoulos A, Langberg J, Eddy L, Silvia P, Labban J. A randomized controlled trial examining CBT for college students with ADHD. J Consult Clin Psychol. 2021;89(1):21–33.

Eddy LD, Anastopoulos AD, Dvorsky MR, Silvia PJ, Labban JD, Langberg JM. An RCT of a CBT intervention for emerging adults with ADHD attending college: functional outcomes. J Clin Child Adolesc Psychol. 2021;50(6):844–57.

Critchfield T, Kollins S. Temporal discounting: basic research and the analysis of socially important behavior. J Appl Behav Anal. 2001;34(1):101–22.

Scheres A, Solanto MV. Do ADHD symptoms, executive function, and study strategies predict temporal reward discounting in college students with varying levels of ADHD symptoms? A pilot study. Brain Sci. 2021;11(2):181.

Solanto MV. Cognitive behavioral therapy for adult ADHD: targeting executive dysfunction. New York: The Guildford Press; 2011.

Lopez PL, Torrente FM, Ciapponi A, Lischinsky AG, Cetkovich-Bakmas M, Rojas JI, et al. Cognitive-behavioural interventions for attention deficit hyperactivity disorder (ADHD) in adults. Cochrane Database Syst Rev. 2013;3(3):CD010840. https://doi.org/10.1002/14651858.CD010840.pub2 .

Hinshaw SP, Arnold LE. ADHD, multimodal treatment, and longitudinal outcome: evidence, paradox, and challenge. Cogn Sci. 2015;6(1):39–52.

Prevatt F, Lampropoulos GK, Bowles V, Garrett L. The use of between session assignments in ADHD coaching with college students. J Atten Disord. 2011;15(1):18–27.

Swartz SL, Prevatt F, Proctor BE. A coaching intervention for college students with attention deficit/hyperactivity disorder. Psychol Sch. 2005;42(6):647–56.

Parker DR, Hoffman SF, Sawilowsky S, Rolands L. Self-control in postsecondary settings. J Atten Disord. 2013;17(3):215–32.

Parker D, Hoffman S, Sawilowsky S, Rolands L. An examination of the effects of ADHD coaching on university students executive functioning. J Postsecondary Educ Disabil. 2011;24:115–32.

Young S, Bramham J. Cognitive-Behavioural therapy for ADHD in adolescents and adults: Wiley-Blackwell; 2012.

Burns D, Danall N, Holt M. Assessing the impact of the COVID-19 pandemic on student wellbeing at universities in the United Kingdom: a conceptual analysis. Front Educ. 2020;5:582882. https://doi.org/10.3389/feduc.2020.582882 .

Stathopoulou T, Mouriki A, Papliou O. Student well-being during the COVID-19 pandemic in Greece. Athens: National Centre for Social Research; 2020.

Van De Velde S, Buffel V, Bracke P, Van Hal G, Wouters E. The COVID-19 international student well-being study. Eur J Pub Health. 2021;31(Supplement_3).

Plakhotnik MS, Volkova NV, Jiang C, Yahiaoui D, Pheiffer G, McKay K, et al. The perceived impact of COVID-19 on student well-being and the mediating role of the university support: evidence from France, Germany, Russia, and the UK. Front Psychol. 2021;12:642689.

Frampton N, Smithies D. University Mental Health: Life in the Pandemic 2020/2021. Leeds: Student Minds; 2021.

Almendingen K, Morseth M, Gjølstad E, Brevik A, Tørris C. Student's experiences with online teaching following COVID-19 lockdown: a mixed methods explorative study. PLoS One. 2021;16(8):e0250378.

Al-Tammemi A, Akour A, Alfalah L. Is it just about physical health? An online cross-sectional study exploring the psychological distress Among University students in Jordan in the midst of COVID-19 pandemic. Front Psychol. 2020;11:562213.

Merzon E, Weiss MD, Cortese S, Rotem A, Schneider T, Craig SG, et al. The association between ADHD and the severity of COVID-19 infection. J Atten Disord. 2022;26(4):491–501. https://doi.org/10.1177/10870547211003659 .

Pollak Y, Shoham R, Dayan H, Gabrieli-Seri O, Berger I. Symptoms of ADHD predict lower adaptation to the COVID-19 outbreak: financial decline, low adherence to preventive measures, psychological distress, and illness-related negative perceptions. J Atten Disord. 2021:108705472110279.

Blackall M, Mistlin A. "Broken and Defeated": UK university students on the impact of COVID rules, The Guardian, at: https://www.theguardian.com/education/2021/jan/11/broken-and-defeated-uk-university-students-on-the-impact-of-covid-rules . 11 Jan 2021.

BBC News, Coronavirus: Inside the secret Covid rave scene: at: https://www.bbc.co.uk/news/av/uk-53283351 . 4 July, 2020.

Reuters, Scuffles and arrests as anti-lockdown protesters march through London: at: https://www.reuters.com/article/uk-britain-protests-idUSKBN2BC092 , 20 March, 2021.

Raghupathi V, Raghupathi W. The influence of education on health: an empirical assessment of OECD countries for the period 1995-2015. Arch Public Health. 2020;78:20.

Webb O, Wyness L, Cotton D. Enhancing Access, Retention, Attainment and Progression in Higher Education: A Review of the Literature Showing Demonstrable Impact, vol. 132. York: Higher Education Academy; 2017.

Clery S, Topper A. Grade point average and student outcomes. Data Notes. 2010;5(1):1–5.

Download references

Acknowledgements

We acknowledge JSM for facilitating the consensus meeting and preparing this manuscript, PA, UMS, for assistance in reviewing and editing drafts of this manuscript. We are grateful to Ms. Sue Curtis for recording the meeting and preparing the transcripts from the meeting.

This research did not receive any funding from public, private, or not-for-profit organisations or agencies.

Author information

Authors and affiliations.

Health and Community Services, Government of Jersey, St Helier, Jersey. Social, Genetic & Developmental Psychiatry, Institute of Psychiatry, Psychology & Neuroscience (IoPPN) & Florence Nightingale Faculty of Nursing, Midwifery & Palliative Care (FNFNM), King’s College London, London, UK

Jane A. Sedgwick-Müller

Adult Neurodevelopmental Service, Health and Community Services, Government of Jersey, St Helier, Jersey. Department of Psychiatry, University of Cambridge, Cambridge, UK

Ulrich Müller-Sedgwick

School of Human and Health Sciences, University of Huddersfield, Huddersfield, UK

Marios Adamou & Rebecca Champ

Natbrainlab, Forensic and Neurodevelopmental Sciences, Institute of Psychiatry, Psychology & Neuroscience (IoPPN), King’s College London, London, UK

Marco Catani

Psychology Department, Institute of Psychiatry, Psychology & Neuroscience (IoPPN), King’s College London, London, UK

Gísli Gudjónsson

Adult ADHD Service, Avon and Wiltshire Mental Health Partnership NHS Trust, Bristol, UK

Dietmar Hank

Adult ADHD and Autism Outpatient Service, South London & Maudsley NHS Foundation Trust, London, UK

Psychology Services Limited, Department of Psychology, Reykjavik University, Reykjavik, Iceland

Susan Young

Social, Genetic & Developmental Psychiatry, Institute of Psychiatry, Psychology & Neuroscience (IoPPN), King’s College London, London, UK

Philip Asherson

You can also search for this author in PubMed   Google Scholar

Contributions

JSM conceived the work; PA, MC, RC were keynote speakers during the meeting; JSM, PA and UMS were involved in drafting the manuscript and critically revising it. A final draft was circulated by JSM to UMS, MA, MC, RC, GG, DH, MP, SY and PA, who endorsed the consensus and approved the manuscript.

Corresponding author

Correspondence to Jane A. Sedgwick-Müller .

Ethics declarations

Ethics approval and consent to participate.

All methods were carried out in accordance with relevant guidelines and regulations.

Consent for publication

Not Applicable.

Competing interests

YES, “JSM, USM, MP, SY, PA have received honoraria and pharmaceutical funding for consultation, research awards, educational talks, study days and/or conference support. JSM is in receipt of an educational grant from the Royal College of Nursing (RCN) Foundation towards PhD tuition fees and received the 2020 RCN Muriel Fleet Award for outstanding professional development and 2020 Genius Within Award for Neurodiverse Research of the Year and all other authors have no other competing interests to disclose.”

Additional information

Publisher’s note.

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ . The Creative Commons Public Domain Dedication waiver ( http://creativecommons.org/publicdomain/zero/1.0/ ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and Permissions

About this article

Cite this article.

Sedgwick-Müller, J.A., Müller-Sedgwick, U., Adamou, M. et al. University students with attention deficit hyperactivity disorder (ADHD): a consensus statement from the UK Adult ADHD Network (UKAAN). BMC Psychiatry 22 , 292 (2022). https://doi.org/10.1186/s12888-022-03898-z

Download citation

Received : 29 September 2021

Accepted : 15 March 2022

Published : 22 April 2022

DOI : https://doi.org/10.1186/s12888-022-03898-z

Share this article

Anyone you share the following link with will be able to read this content:

Sorry, a shareable link is not currently available for this article.

Provided by the Springer Nature SharedIt content-sharing initiative

• Attention-deficit/hyperactivity disorder
• Academic performance
• Academic achievement
• University students
• Educational outcomes
• Higher education

BMC Psychiatry

ISSN: 1471-244X

• Submission enquiries: [email protected]
• General enquiries: [email protected]

Log in using your username and password

• Search More Search for this keyword Advanced search
• Latest content
• Current issue
• For authors
• BMJ Journals More You are viewing from: Google Indexer

You are here

• Volume 90, Issue suppl 1
• The effect of ADHD on the life of an individual, their family, and community from preschool to adult life
• Article Text
• Article info
• Citation Tools
• Rapid Responses
• Article metrics

• Correspondence to: Dr V A Harpin Ryegate Children’s Centre, Sheffield Children’s NHS Trust, Tapton Crescent Road, Sheffield S10 5DD, UK; Val.Harpinsheffch-tr.trent.nhs.uk

Attention deficit/hyperactivity disorder (ADHD) may affect all aspects of a child’s life. Indeed, it impacts not only on the child, but also on parents and siblings, causing disturbances to family and marital functioning. The adverse effects of ADHD upon children and their families changes from the preschool years to primary school and adolescence, with varying aspects of the disorder being more prominent at different stages. ADHD may persist into adulthood causing disruptions to both professional and personal life. In addition, ADHD has been associated with increased healthcare costs for patients and their family members.

• CHQ, Child Health Questionnaire
• ODD, oppositional defiant disorder

http://dx.doi.org/10.1136/adc.2004.059006

Statistics from Altmetric.com

Request permissions.

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Attention deficit/hyperactivity disorder (ADHD) is a chronic, debilitating disorder which may impact upon many aspects of an individual’s life, including academic difficulties, 1 social skills problems, 2 and strained parent-child relationships. 3 Whereas it was previously thought that children eventually outgrow ADHD, recent studies suggest that 30–60% of affected individuals continue to show significant symptoms of the disorder into adulthood. 4 Children with the disorder are at greater risk for longer term negative outcomes, such as lower educational and employment attainment. 5 A vital consideration in the effective treatment of ADHD is how the disorder affects the daily lives of children, young people, and their families. Indeed, it is not sufficient to merely consider ADHD symptoms during school hours—a thorough examination of the disorder should take into account the functioning and wellbeing of the entire family.

As children with ADHD get older, the way the disorder impacts upon them and their families changes (fig 1 ⇓ ). The core difficulties in executive function seen in ADHD 7 result in a different picture in later life, depending upon the demands made on the individual by their environment. This varies with family and school resources, as well as with age, cognitive ability, and insight of the child or young person. An environment that is sensitive to the needs of an individual with ADHD and aware of the implications of the disorder is vital. Optimal medical and behavioural management is aimed at supporting the individual with ADHD and allowing them to achieve their full potential while minimising adverse effects on themselves and society as a whole.

• Download figure
• Open in new tab
• Download powerpoint

 Stages of ADHD. Adapted from Kewley G (1999). 6

The aim of this paper is to follow the natural history of this complex disorder through preschool years, school life, and adulthood and to consider its effect on the family, the community, and society as a whole. In addition, comorbidities and healthcare costs are examined.

THE PRESCHOOL CHILD

Poor concentration, high levels of activity, and impulsiveness are frequent characteristics of normal preschool children. Consequently, a high level of supervision is the norm. Even so, children with ADHD may still stand out. In this age group there is often unusually poor intensity of play and excessive motor restlessness. 8, 9 Associated difficulties, such as delayed development, oppositional behaviour, and poor social skills, may also be present. If ADHD is a possibility, it is vital to offer targeted parenting advice and support. Even at this early stage parental stress may be huge when a child does not respond to ordinary parental requests and behavioural advice. 9 Targeted work with preschool children and their carers has been shown to be effective in improving parent child interaction and reducing parental stress. 10, 11 A useful review of the available evidence and methods is provided by Barkley. 12

PRIMARY SCHOOL YEARS

The primary school child with ADHD frequently begins to be seen as being different as classmates start to develop the skills and maturity that enable them to learn successfully in school. Although a sensitive teacher may be able to adapt the classroom to allow an able child with ADHD to succeed, more frequently the child experiences academic failure, rejection by peers, and low self esteem (fig 2 ⇓ ). Comorbid problems, such as specific learning difficulties, may also start to impact on the child, further complicating diagnosis and management. Assessment by an educational psychologist may help to unravel learning strengths and difficulties, and advise on necessary support in the classroom.

 Emotional and family functioning in children with ADHD compared with controls. 13 *Higher scores indicative of greater functioning. CHQ, Child Health Questionnaire. 13

Frequently, difficulties at home or on outings with carers (for example, when shopping, out in the park, or visiting other family members) also become more apparent at this age. Parents may find that family members refuse to care for the child, and that other children do not invite them to parties or out to play. Many children with ADHD have very poor sleep patterns, and although they appear not to need much sleep, daytime behaviour is often worse when sleep is badly affected. As a result, parents have little time to themselves; whenever the child is awake they have to be watching them. Not surprisingly, family relationships may be severely strained, and in some cases break down, bringing additional social and financial difficulties. 14 This may cause children to feel sad or even show oppositional or aggressive behaviour.

Assessing the quality of life of the child suffering from ADHD is difficult. Behavioural assessments are usually carried out by parents, teachers, or healthcare professionals, and it can usually only be inferred how the child must feel. However, data from self evaluations indicate that children with ADHD view their most problematic behaviour as less within their control and more prevalent than children without ADHD. 15 Participation in a school based, nurse led support group was associated with an increase in self worth in pre-adolescents with ADHD. 16

Johnston and Mash reviewed the evidence of the effect of having a child with ADHD on family functioning. 14 They concluded that the presence of a child with ADHD results in increased likelihood of disturbances to family and marital functioning, disrupted parent-child relationships, reduced parenting efficacy, and increased levels of parent stress, particularly when ADHD is comorbid with conduct problems.

In a survey of the mothers and fathers of 66 children, parents of children with ADHD combined and inattentive subtypes expressed more role dissatisfaction than parents of control children. 17 Furthermore, ADHD in children was reported to predict depression in mothers. 18 Pelham et al reported that the deviant child behaviours that represent major chronic interpersonal stressors for parents of ADHD children are associated with increased parental alcohol consumption. 19

Limited attention has been given to sibling relationships in families with ADHD children. While it has been reported that siblings of children with ADHD are at increased risk for conduct and emotional disorders, 20 a more recent study presenting sibling accounts of ADHD identified disruption caused by symptoms and behavioural manifestations of ADHD as the most significant problem. 21 This disruption was experienced by siblings in three primary ways: victimisation, caretaking, and sorrow and loss. Siblings reported feeling victimised by aggressive acts from their ADHD brothers through overt acts of physical violence, verbal aggression, and manipulation and control. In addition, siblings reported that parents expected them to care for and protect their ADHD brothers because of the social and emotional immaturity associated with ADHD. Furthermore, as a result of the ADHD symptoms and consequent disruption, many siblings described feeling anxious, worried, and sad. 21

Broader social and family functioning has been assessed using the Child Health Questionnaire (CHQ), a parent rated health outcome scale that measures physical and psychosocial wellbeing. 22– , 24 The studies demonstrated that treatment of ADHD with atomoxetine, a new non-stimulant medication for ADHD, resulted in improved perception of quality of life, with improvements being apparent in social and family functioning, and self esteem. Further research assessing the ongoing quality of life for the child and their family following multimodal input is urgently needed.

ADHD IN YOUNG PEOPLE

Adolescence may bring about a reduction in the overactivity that is often so striking in younger children, but inattention, impulsiveness, and inner restlessness remain major difficulties. A distorted sense of self and a disruption of the normal development of self has been reported by adolescents with ADHD. 25 Furthermore, excessively aggressive and antisocial behaviour may develop, adding further problems (fig 3 ⇓ ). A study by Edwards et al 27 examined teenagers with ADHD and oppositional defiant disorder (ODD), which is defined by the presence of markedly defiant, disobedient, provocative behaviour and by the absence of more severe dissocial or aggressive acts that violate the law or the rights of others. These teenagers rated themselves as having more parent-teen conflict than did community controls. Increased parent-teen conflict was also reported when parents of teenagers with ADHD carried out the rating exercise. In addition, a survey of 11–15 year olds showed that those with hyperkinesis were twice as likely as the overall population to have “a severe lack of friendship”. 28

 Antisocial behaviour in adolescents with ADHD. 26 Data primarily represents outcomes in those with conduct disorder as teenagers.

Young people with ADHD are at increased risk of academic failure, dropping out of school or college, teenage pregnancy, and criminal behaviour (fig 4A ⇓ and B). Driving poses an additional risk. Individuals with ADHD are easily distracted from concentrating on driving when going slowly, but while driving fast may also be dangerous. It has been shown that, compared with age matched controls, drivers with ADHD are at increased risk of traffic violations, especially speeding, and are considered to be at fault in more traffic accidents, including fatal ones (fig 5 ⇓ ). 30 The risk of such events was increased further by the presence of concomitant ODD. 29 However, it has been suggested that treatment may have a positive effect on driving skills. 31

 Impact of ADHD in adolescence. Data from Barkley RA; 26 (A) Impact at school; (B) impact on health, social, and psychiatric wellbeing.

 Driving-related offences in young adults with ADHD and controls. NS, not significant. Data from Barkley RA et al . 29

As many as 60% of individuals with ADHD symptoms in childhood continue to have difficulties in adult life. 32, 33 Adults with ADHD are more likely to be dismissed from employment and have often tried a number of jobs before being able to find one at which they can succeed. 5 They may need to choose specific types of work and are frequently self employed. In the workplace, adults with ADHD experience more interpersonal difficulties with employers and colleagues. Further problems are caused by lateness, absenteeism, excessive errors, and an inability to accomplish expected workloads. At home, relationship difficulties and break-ups are more common. The risk of drug and substance abuse is significantly increased in adults with persisting ADHD symptoms who have not been receiving medication. 34 The genetic aspects of ADHD mean that adults with ADHD are more likely to have children with ADHD. This in turn causes further problems, especially as the success of parenting programmes for parents of children with ADHD is highly influenced by the presence of parental ADHD. 35 Thus, ADHD in parents and children can lead to a cycle of difficulties.

COMORBIDITIES

Comorbid disorders may impact on individuals with ADHD throughout their lives. It is estimated that at least 65% of children with ADHD have one or more comorbid conditions. 36 The reported incidence of some of the most frequent comorbidities is shown in figure 6 ⇓ , with neurodevelopmental problems, such as dyslexia and developmental coordination disorder, being particularly common. Many children with ADHD also suffer from tic disorders (not related to stimulant medication). In addition, around 60% of children with Tourette’s Syndrome fulfil criteria for ADHD, 38, 39 and autistic spectrum disorder is increasingly recognised with comorbid ADHD. 39 Initially, excessive hyperactivity may mask the features of autistic spectrum disorder until the child receives medication. Conduct disorder and ODD coexist with ADHD in at least 30%, and in some reports up to 90%, of cases. 36 These most frequently occurring comorbidities can, however, be considered more as complications of ADHD, with adversity in their psychological environment possibly determining whether children at risk make the transition to antisocial conduct. 40

 ADHD and comorbidity in Swedish school age children. 37 MR, mental retardation; RWD, reading/writing disorder; DC, developmental coordination; ODD, oppositional defiant disorder.

PROBLEMS ASSOCIATED WITH TREATMENT

Growth deficits in children receiving stimulant treatment for ADHD have long been the subject of scientific discussion. Conflicting results have been reported with some authors indicating that stimulants do indeed affect growth in children, 41– , 43 but that this only occurs during active treatment phase and does not compromise final height. 44 Other studies, however, have not found any evidence to suggest that stimulants influence growth. 45, 46 Taken together, the results suggest that clinicians should monitor the growth of hyperactive children receiving stimulants, and consider dose reduction in individual cases should evidence of growth suppression occur.

Another frequently quoted concern about treatment of ADHD with stimulant medications is that it could lead to drug addiction in later life. Young people with ADHD are by nature impulsive risk takers, and there is clear evidence that untreated ADHD—especially with concomitant conduct disorder—is associated with a three- to fourfold increase in the risk of substance misuse. 47, 48 In contrast, patients medicated with stimulants have a similar risk of substance misuse to controls. 49 These data therefore provide strong evidence in favour of careful treatment and support for young people with ADHD.

HEALTHCARE COSTS

Healthcare costs for individuals with ADHD in the UK have not been fully estimated, but evidence from the USA suggests that they are increased compared with age matched controls. A population based, historical cohort study followed 4880 individuals from 1987 to 1995 and compared the nine year median medical cost per person: ADHD medical costs were US$4306, whereas non-ADHD medical costs were US$1944 (p<0.01). 50 These findings are likely to reflect increased injury following accidents and a rise in use of substance abuse services and other outpatient facilities, although poor ability to comply with advice on medication (for example, asthma management) may also be implicated. A study of the injuries to children with ADHD established that children with ADHD were more likely to be injured as pedestrians or bicyclists than children not suffering from ADHD. They were more likely to sustain injuries to multiple body regions, head injuries, and to be severely injured. 51 ADHD has been found to represent a risk factor for substance abuse, 47, 52 and an investigation of prevalence of ADHD among substance abusers has established that ADHD was significantly overrepresented among inpatients with psychoactive substance use disorder. 53 Increased use of health services is also seen in the relatives of individuals with ADHD. A study has shown that direct and indirect medical costs were twice as high as those of family members of a control group. 54 The difference in these costs was primarily due to a higher incidence of mental health problems in the family members of ADHD patients, which reflects the increased stresses and demands of living with an adult or child with ADHD. Indeed, ADHD related family stress has been linked to increased risk of parental depression and alcohol related disorders. 55– , 57

It is vital to consider the role of treatment of ADHD in decreasing the individual’s risk of adverse outcomes. A number of studies on the effect of treatment of ADHD on the risk of substance abuse encouragingly demonstrate a fall in risk to that of the normal population. 58– , 60

Mannuzza’s review of the long term prognosis in ADHD concludes that childhood ADHD does not preclude high educational and vocational achievements (for example, Master’s degree or medical qualification). 61 However, ADHD is a disorder that may affect all aspects of a child’s life. Careful assessment is paramount, and if this demonstrates significant impairment as a result of ADHD, there is clear evidence that treatment of ADHD should be instituted. 62, 63 Current treatment focuses mainly on the short term relief of core symptoms, mainly during the school day. This means that important times of the day, such as early mornings before school and evening to bedtime, are frequently unaffected by current treatment regimes. This can negatively impact on child and family functioning and fail to optimise self esteem and long term mental health development.

In 2003, the American Academy of Pediatrics recommended that clinicians should work with children and their families to monitor the success (or failure) of treatment, using certain criteria to assess specific areas of difficulty and quality of life as a whole. 64 There has been a reluctance in the UK to treat ADHD with medication, fuelled by concerns about possible over-prescription in the USA. In addition, newspaper and media coverage of ADHD is often negative and stigmatising. The evidence of potentially severe difficulties for the child, the family, and, in some cases, for society as a whole, means that coordinated multi-agency effort to support the child and family is essential. Moreover, healthcare professionals have an important role in providing balanced and supportive information about ADHD and meeting the needs of affected individuals and their families.

• ↵ Faraone SV , Biederman J, Monuteaux MC, et al. A psychometric measure of learning disability predicts educational failure four years later in boys with ADHD. J Atten Disord 2001 ; 4 : 220 –30.
• ↵ Bagwell CL , Molina BS, Pelham WE, et al. ADHD and problems in peer relations: Predictions from childhood to adolescence. J Am Acad Child Adolesc Psychiatry 2001 ; 40 : 1285 –92. OpenUrl CrossRef PubMed Web of Science
• ↵ Johnston C , Mash EJ. Families of children with ADHD: review and recommendations for future research. Clin Child Fam Psychol Rev 2001 ; 4 : 183 –207. OpenUrl CrossRef PubMed Web of Science
• ↵ Weiss G , Hechtman L. Hyperactive children grown up: ADHD in children, adolescents and adults . New York: Guildford, 1993 .
• ↵ Mannuzza S , Klein RG, Bessler A, et al. Adult outcome of hyperactive boys. Educational achievement, occupational rank and psychiatric status. Arch Gen Psychiatry 1993 ; 50 : 565 –76. OpenUrl CrossRef PubMed Web of Science
• ↵ Kewley GD . Attention deficit hyperactivity disorder: Recognition, reality and resolution . London: David Fulton Publishers, 1999 .
• ↵ Barkley RA . Behavioral inhibition, sustained attention, and executive functions: constructing a unifying theory of ADHD. Psychol Bull 1997 ; 121 : 65 –94. OpenUrl CrossRef PubMed Web of Science
• ↵ Alessandri SM . Attention, play, and social behaviour in ADHD preschoolers. J Abnorm Child Psychol 1992 ; 20 : 289 –302. OpenUrl CrossRef PubMed
• ↵ DuPaul GJ , McGoey KE, Eckert TL, et al. Preschool children with attention-deficit/hyperactivity disorder: impairments in behavioural, social, and school functioning. J Am Acad Child Adolesc Psychiatry 2001 ; 40 : 508 –15. OpenUrl CrossRef PubMed Web of Science
• ↵ Sonuga-Barke EJ , Daley D, Thompson M, et al. Parent-based therapies for preschool attention-deficit/hyperactivity disorder: a randomised, controlled trial with a community sample. J Am Acad Child Adolesc Psychiatry 2001 ; 40 : 402 –8. OpenUrl CrossRef PubMed Web of Science
• ↵ Barton J . PhD Thesis. The effect of modifying maternal expressed emotion on outcome of preschool hyperactivity . University of Glasgow 2002 .
• ↵ Barkley R . Psychosocial treatments for attention-deficit/hyperactivity disorder in children. J Clin Psychiatry 2002 ; 63 : 36 –43.
• ↵ Landgraf JM , Abetz L, Ware JE. The CHQ User’s Manual , 2nd edition. Boston: HealthAct, 1999 .
• ↵ Johnston C , Mash EJ. Families of children with attention-deficit/hyperactivity disorder: review and recommendations for future research. Clin Child and Fam Psychol Rev 2001 ; 4 : 183 –207.
• ↵ Kaidar I , Wiener J, Tannock R. The attributions of children with attention-deficit/hyperactivity disorder for their problem behaviors. J Atten Disord 2003 ; 6 : 99 –109. OpenUrl CrossRef PubMed
• ↵ Frame K , Kelly L, Bayley E. Increasing perceptions of self-worth in preadolescents diagnosed with ADHD. J Nurs Scholarsh 2003 ; 35 : 225 –9. OpenUrl CrossRef PubMed Web of Science
• ↵ Podolski CL , Nigg JT. Parent stress and coping in relation to child ADHD severity and associated child disruptive behaviour problems. J Clin Child Psychol 2001 ; 30 : 503 –13. OpenUrl CrossRef PubMed Web of Science
• ↵ Faraone SV , Biederman J, Chen WJ, et al. Genetic heterogeneity in attention-deficit hyperactivity disorder (ADHD): gender, psychiatric comorbidity, and maternal ADHD. J Abnorm Psychol 1995 ; 104 : 334 –45. OpenUrl CrossRef PubMed Web of Science
• ↵ Pelham WE Jr , Lang AR. Can your children drive you to drink? Stress and parenting in adults interacting with children with ADHD. Alcohol Res Health 1999 ; 23 : 292 –8. OpenUrl PubMed Web of Science
• ↵ Szatmari P , Offord DR, Boyle MH. Ontario Child Health Study: prevalence of attention deficit disorder with hyperactivity. J Child Psychol Psychiatry 1989 ; 30 : 219 –30. OpenUrl CrossRef PubMed Web of Science
• ↵ Kendall J , Siblings accounts of attention deficit hyperactivity disorder. Family Proc 1999 ; 38 : 117 –36.
• ↵ Michelson D , Faries D, Wernicke J, et al. Atomoxetine in the treatment of children and adolescents with attention-deficity/hyperactivity disorder: a randomised, placebo-controlled, dose response study. Pediatrics 2001 ; 108 : 1 –9. OpenUrl Abstract / FREE Full Text
• Barton J , Prasad S, Buitelaar JK, et al. 10-week, open-label, acute treatment with atomoxetine in non-North American children with ADHD. Poster presented at the Royal College of Psychiatrists Annual General Meeting. Edinburgh, UK, 30 June–3 July 2003 .
• ↵ Harpin V . Changes in quality of life in patients with attention-deficit-hyperactivity disorder after atomoxetine treatment. Paper presented at the meeting of the European Academy of Childhood Disability (EACD). Norway: Oslo, 2–4 October, 2003 .
• ↵ Krueger M , Kendall J. Descriptions of self: an exploratory study of adolescents with ADHD. J Child Adolesc Psychiatr Nurs 2001 ; 14 : 61 –72. OpenUrl PubMed
• ↵ Barkley RA . Attention deficit hyperactivity disorder: A handbook for diagnosis and treatment , 2nd edition. New York: Guildford Press, 1998 .
• ↵ Edwards G , Barkley RA, Laneri M, et al. Parent–adolescent conflict in teenagers with ADHD and ODD. J Abnormal Child Psychology 2001 ; 29 : 557 –72. OpenUrl CrossRef PubMed Web of Science
• ↵ Meltzer H , Gatward R, Goodman R, et al. The mental health of children and adolescents in Great Britain . Office for National Statistics, London: The Stationery Office, 2000 .
• ↵ Barkley RA , Guevremont DC, Anastopoulos AD, et al. Driving-related risks and outcomes of attention deficit hyperactivity disorder in adolescents and young adults: A 3 to 5 year follow up survey. Pediatrics 1993 ; 92 : 212 –18. OpenUrl Abstract / FREE Full Text
• ↵ Barkley RA , Murphy KR, Kwasnik D. Motor vehicle driving competencies and risks in teens and young adults with attention deficit hyperactivity disorder. Pediatrics 1996 ; 98 : 1089 –95. OpenUrl Abstract / FREE Full Text
• ↵ Cox DJ , Merkel RL, Penberthy JK, et al. Impact of methylphenidate delivery profiles on driving performance of adolescents with attention-deficit/hyperactivity disorder: a pilot study. J Am Acad Child Adolesc Psychiatry 2004 ; 43 : 269 –75. OpenUrl CrossRef PubMed Web of Science
• ↵ Weiss G , Hechtman L, Milroy T, et al. Psychiatric status of hyperactives as adults: a controlled prospective 15-year follow-up of 63 hyperactive children. J Am Acad Child Psychiatry 1985 ; 24 : 211 –20. OpenUrl CrossRef PubMed Web of Science
• ↵ Weiss M , Hechtman L, Weiss G. ADHD in Adulthood—A guide to current theory, diagnosis and treatment . Baltimore: Johns Hopkins University Press, 1999 .
• ↵ Biederman J , Wilens TE, Mick E, et al. Does attention-deficit hyperactivity disorder impact the development course of drug and alcohol abuse and dependence? Biol Psychiatry 1998 ; 44 : 269 –73. OpenUrl CrossRef PubMed Web of Science
• ↵ Sonuga-Barke EJ , Daley D, Thompson M. Does maternal ADHD reduce the effectiveness of parent training for preschool children’s ADHD? J Am Acad Child Adolesc Psychiatry 2002 ; 41 : 696 –702. OpenUrl CrossRef PubMed
• ↵ Biederman J , Newcom J, Sprich S. Comorbidity of attention deficit hyperactivity disorder with conduct, depressive, anxiety and other disorders. Am J Psychiatry 1991 ; 148 : 564 –77. OpenUrl CrossRef PubMed Web of Science
• ↵ Kadesjo B , Gillberg C. The comorbidity of ADHD in the general population of Swedish school-age children. J Child Psychol Psychiatry 2001 ; 42 : 487 –92. OpenUrl CrossRef PubMed Web of Science
• ↵ Freeman RD , Fast DK, Burd L, et al. An international perspective on Tourette syndrome: selected findings from 3,500 individuals in 22 countries. Dev Med Child Neurol 2000 ; 42 : 436 –47. OpenUrl CrossRef PubMed Web of Science
• ↵ Gillberg C , Gillberg IC, Rasmussen P, et al. Co-existing disorders in ADHD—implications for diagnosis and intervention. Eur Child Adolesc Psychiatry 2004 ; 13 (Suppl 1) : I80 –92.
• ↵ Taylor E . Clinical foundations of hyperactivity research. Behav Brain Res 1998 ; 94 : 11 –24. OpenUrl CrossRef PubMed Web of Science
• ↵ Mattes JA , Gittelman R. Growth of hyperactive children on maintenance regimen of methylphenidate. Arch Gen Psychiatry 1983 ; 40 : 317 –21. OpenUrl CrossRef PubMed Web of Science
• Lisska MC , Rivkees SA. Daily methylphenidate use slows the growth of children: a community based study. J Pediatr Endocrinol Metab 2003 ; 16 : 711 –18. OpenUrl PubMed Web of Science
• ↵ Poulton A , Cowell CT. Slowing of growth in height and weight on stimulants: a characteristic pattern. J Paediatr Child Health 2003 ; 39 : 180 –5. OpenUrl CrossRef PubMed Web of Science
• ↵ Klein RG , Mannuzza S. Hyperactive boys almost grown up. III. Methylphenidate effects on ultimate height. Arch Gen Psychiatry 1988 ; 45 : 1131 –4. OpenUrl CrossRef PubMed Web of Science
• ↵ Spencer T , Biederman J, Wilens T. Growth deficits in children with attention deficit hyperactivity disorder. Pediatrics 1998 ; 102 : 501 –6. OpenUrl PubMed Web of Science
• ↵ Biederman J , Faraone SV, Monuteaux MC, et al. Growth deficits and attention-deficit/hyperactivity disorder revisited: impact of gender, development, and treatment. Pediatrics 2003 ; 111 : 1010 –16. OpenUrl Abstract / FREE Full Text
• ↵ Biederman J , Wilens TE, Mick E, et al. Does attention-deficit hyperactivity disorder impact the developmental course of drug and alcohol abuse and dependence? Biol Psychiatry 1998 ; 44 : 269 –73.
• ↵ Wilens TE . Impact of ADHD and its treatment on substance abuse in adults. J Clin Psychiatry 2004 ; 65 (Suppl 3) : 38 –45.
• ↵ Biederman J , Wilens T, Mick E, et al. Pharmacotherapy of attention-deficit/hyperactivity disorder reduces risk for substance use disorder. Pediatrics 1999 ; 104 : e20 . OpenUrl Abstract / FREE Full Text
• ↵ Leibson CL , Katusic SK, Barbaresi WJ, et al. Use and costs of medical care for children and adolescents with and without attention-deficit/hyperactivity disorder. JAMA 2001 ; 285 : 60 –6. OpenUrl CrossRef PubMed Web of Science
• ↵ DiScala C , Lescohier I, Barthel M, et al. Injuries to children with attention deficit hyperactivity disorder. Pediatrics 1998 ; 102 : 1415 –21. OpenUrl Abstract / FREE Full Text
• ↵ Sullivan MA , Rudnik-Levin F. Attention deficit/hyperactivity disorder and substance abuse. Diagnostic and therapeutic considerations. Ann N Y Acad Sci 2001 ; 931 : 251 –70. OpenUrl PubMed Web of Science
• ↵ Schubiner H , Tzelepis A, Milberger S, et al. Prevalence of attention-deficit/hyperactivity disorder and conduct disorder among substance abusers. J Clin Psychiatry 2000 ; 61 : 244 –51. OpenUrl CrossRef PubMed Web of Science
• ↵ Swensen AR , Birnbaum HG, Secnik K, et al. Attention-deficit/hyperactivity disorder: increased costs for patients and their families. J Am Acad Child Adolesc Psychiatry 2003 ; 42 : 1415 –23. OpenUrl CrossRef PubMed Web of Science
• ↵ Cunningham CE , Benness BB, Siegel LS. Family functioning, time allocation, and parental depression in the families of normal and ADHD children. J Clin Child Psychol 1988 ; 17 : 169 –77. OpenUrl CrossRef Web of Science
• Brown RT , Pacini JN. Perceived family functioning, marital status, and depression in parents of boys with attention deficit disorder. J Learn Disabil 1989 ; 22 : 581 –7.
• ↵ Hankin CS . ADHD and its impact on the family. Drug Benefit Trends 2001 ; 13 (Suppl C) : 15 –16.
• ↵ Huss M , Lehmkuhl U. Methylphenidate and substance abuse: a review of pharmacology, animal and clinical studies. J Atten Disord 2002 ; 6 (Suppl 1) : S65 –71.
• Faraone SV , Wilens T. Does stimulant treatment lead to substance use disorders? J Clin Psychiatry 2003 ; 64 (Suppl 1) : 9 –13. OpenUrl PubMed
• ↵ Mannuzza S , Klein RG, Moulton JL 3rd. oes stimulant treatment place children at risk for adult substance abuse? A controlled, prospective follow-up study. J Child Adolesc Psychopharmacol 2003 ; 13 : 273 –82. OpenUrl CrossRef PubMed Web of Science
• ↵ Mannuzza S , Klein RG. Long-term prognosis in attention-deficit/hyperactivity disorder. Child Adolesc Psychiatr Clin N Am 2000 ; 9 : 711 –26. OpenUrl PubMed Web of Science
• ↵ National Institute for Clinical Excellence (NICE) . Guidance on the use of methylphenidate (Ritalin, Equasym) for attention deficit/hyperactivity disorder (ADHD) in childhood. Health Technology Assessment No 13 . October 2000 .
• ↵ The MTA Cooperative Group . A 14-month randomised clinical trial of treatment strategies for attention-deficit/hyperactivity disorder. Arch Gen Psychiatry 1999 ; 56 : 1073 –86. OpenUrl CrossRef PubMed Web of Science
• ↵ American Academy of Pediatrics , Reiff MI , Tippins S. ADHD—A Complete and Authoritative Guide . Chicago: Independent Publishers Group, 2003 .

Linked Articles

• Editorial Introduction P Hill Archives of Disease in Childhood 2005; 90 i1-i1 Published Online First: 21 Jan 2005. doi: 10.1136/adc.2004.058842

Read the full text or download the PDF: